Search
Controlling High Blood Pressure — Measure 236
Controlling High Blood Pressure ... DESCRIPTION: Percentage of patients 18–85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled (<140/90 mmHg) during the measurement
Incretin-based therapy for diabetes and dermatology: Promise and peril
By Warren R. Heymann, MD Oct. 23, 2017 In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes. ... Incretin hormones refer to
Session handouts and meetings archive
Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation
Neurofibromatosis type 1, juvenile xanthogranuloma, and leukemia: Wasting a good worry?
By Warren R. Heymann, MD May 22, 2017 A clinically pigmented neurofibroma associated with underlying café au lait macule. ... Credit: ... JAAD Worry comes with the territory of Neurofibromatosis Type I (NF-1). It often starts with the anxiety of determining if a child has enough criteria to confirm the
Are you at risk for pityriasis rubra type V? It’s in the cards!
By Warren R. Heymann, MD Feb. 1, 2017 Characteristic facial involvement in caspase recruitment domain family member 14 gene (CARD14)-associated papulosquamous eruption. Symmetric and geometric pink, scaly patches or plaques involving the cheeks, upper cutaneous lip, and chin with sparing of the infralabial region is highly characteristic of CARD14-associated papulosquamous
October 12, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 12, 2022 ... Type 2 diabetes and CCCA severity DermWorld Insights and Inquiries : Fixing the concept of the neutrophilic fixed drug eruption What’s the risk of IBD in patients
CME & session evaluation archive
Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023
What MIPS deadlines are coming up and when do I have to submit?
Asked and Answered ... September 2, 2019 Mark your calendars with the following MIPS reporting deadlines: Oct. 2, 2019: ... Last day to begin an improvement activity (IA) or participate in promoting interoperability (PI) measures as these require 90 consecutive days of engagement ... Dec. 1, 2019 ... (for EHR
Secukinumab for pityriasis rubra pilaris: Tread lightly
By Warren R. Heymann, MD Nov. 17, 2016 Every dermatology resident preparing for their board examination can rattle off Griffiths’ classification of pityriasis rubra pilaris (PRP) — Type I (Classical Adult), Type II (Atypical Adult), Type III (Classic Juvenile), Type IV (Circumscribed Juvenile), and Type V (Atypical Juvenile). Type VI,
The journey of focal dermal hypoplasia: From description to inspired therapy
By Warren R. Heymann, MD Oct. 9, 2017 The dermatologic community lost a giant in 2014 with the passing of Robert W. Goltz, MD at the age of 90. Dr. Goltz was not only responsible for describing focal dermal hypoplasia (FDH), but also multicentric reticulohistiocytosis, generalized elastolysis, and the nevoid
Skin conditions by the numbers
Acne ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (2) A
Ustekinumab: A topic for atopics?
By Warren R. Heymann, MD Jan. 9, 2017 Atopic dermatitis patient shows drastic improvement at week 19 of ustekinumab treatment. ... Credit: ... JAAD If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
Cannabinoids may elevate therapy for connective tissue diseases to a higher level
By Warren R. Heymann, MD Nov. 2, 2017 Medical "reefer madness" is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of
OIG report supported dermatologists’ use of modifier 25, CMS requires no further actions
A recent report by the Office of the Inspector General found that dermatologists are appropriately using modifier 25 the vast majority of the time. The report was compiled in response to scrutiny by CMS of how dermatologists use the modifier. In 90 out of 100 instances sampled, dermatologists are following
May 2
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / MAY 2, 2018 ... The clock is ticking: Only a few days left to review your Sunshine Act info PBMs cutting copay coupons from patient deductibles — which could mean soaring
Smoke and the skin
Experts discuss the cutaneous impact of occupational and natural exposure to smoke. ... Feature ... By Emily Margosian, Senior Editor, June 1, 2025 From wildfires to cigarettes, smoke drifts through every corner of life. ... Nearly 90% of the world’s population lives with unhealthy air caused by smoke, according to
November 18, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / November 18, 2020 ... Hydrogen peroxide and the common wart: Phase 2 results are in DermWorld Insights and Inquiries : Granulomatous slack skin — More than one type of mimicry FDA
The opioid epidemic: Coma blisters and beyond
By Warren R. Heymann, MD Aug. 4, 2017 The opioid crisis in the United States is responsible for at least 90 fatalities every day. This dire situation has been aggravated by the increased availability of very potent synthetic opioids such as fentanyl and carfentanil, which are 50 and 5000 times
Getting a leg up on squamous cell carcinomas of the teratoacanthoma type
By Warren R. Heymann, MD Oct. 8, 2016 I thought it was my imagination, but apparently not — there is distinct subset of patients, mostly mature women, with squamous cell carcinomas (SCC) of the keratoacanthoma type (KA) usually presenting on the anterior distal lower extremities. ... These patients are not
October 2, 2019
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 2, 2019 ... Does gluten increase risk for psoriasis and AD in women? DW Insights and Inquiries : Cutting giant congenital nevi down to size molecularly Upcoming coding changes: Differentiating
Will PD-1 inhibitors be msed for Mastocytosis?
By Warren R. Heymann, MD May 8, 2016 Kuklinski L, Kim J. Expression of PD-L1 in mastocytosis. J Am Acad Dermatol 2016; 74: 1010-2. ... The authors evaluated 16 specimens from 12 patients with mastocytosis, using immunohistochemical stains for PD-L1, CD-117, and mast cell tryptase on all specimens. Of the12
Focusing attention on X-linked ichthyosis
Ichthyosis vulgaris ... Credit: ... JAAD By Warren R. Heymann, MD Jan. 2, 2019 I thought it was me. Like every dermatologist, I learned the classical appearance of the ichthyoses, and wonder why I’m not sure if I am looking at a patient with ichthyosis vulgaris (IV) or X-linked ichthyosis
Direct-to-consumer telemedicine websites: Caveat emptor, a prediction, and proposal
By Warren R. Heymann, MD ... July 17, 2016 ... Two weeks ago, I experienced pain extending from my right groin to my buttock to the degree that I almost could not bear weight. I felt as though I was 90, and if anyone saw my gait, they would have
Lipodystrophia semicircularis: A lipoatrophy not to get depressed about
By Warren R. Heymann, MD, FAAD Nov. 2, 2022 Vol. 4, No. 44 A colleague asked me if I could evaluate his 26-year-old daughter while she was briefly on break from her graduate studies in Barcelona. He was concerned that she had developed lipodystrophy. Of course, I agreed, without his
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Psoriasis: Clinical Response to Systemic Medications ... DESCRIPTION: The percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels. ... ... MEASURE ID: ... 410 ... ... Type: Outcome ... ... CMS Derm Specialty Set: ... Yes ...
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Psoriasis: Clinical Response to Systemic Medications ... DESCRIPTION: The percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels. ... ... MEASURE ID: ... 410 ... ... Type: Intermediate outcome ... ... CMS Derm Specialty Set: ... Yes
Glomus tumors point a finger at neurofibromatosis
By Warren R. Heymann, MD ... Nov. 21, 2016 ... The correct diagnosis of the ... JAMA Dermatology Clinicopathological Correlation of a glomus tumor presenting as longitudinal erythronychia was straightforward — I was fascinated by this comment in the discussion: "The presence of multiple glomus tumors in the digits
Multiple café au lait spots in fair skinned children without evidence of neurofibromatosis type 1: Don’t SPRE(A)D the word – yet
By Warren R. Heymann, MD Oct. 13, 2016 Café au lait spots (CALS) are extraordinarily common; six or more lesions (at least 0.5 cm prior to puberty or 1.5 cm post puberty) are considered one of the criteria for diagnosing neurofibromatosis type I (NF1), and are also seen in
Other emerging severe and resistant dermatophytes of concern
Overview ... Trichophyton mentagrophytes type VII (TMV ... II ... ) is a recently emerged dermatophyte that is closely related to ... T. indotineae (note: ... T. indotineae was previously called ... T. mentagrophytes type ... VIII ... ). ... 1-3 ... TMVII spreads between people and may be transmitted
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Gains in Patient Activation Measure (PAM®) Scores at 12 Months ... DESCRIPTION: The Patient Activation Measure (PAM) is a 10- or 13-item questionnaire that assesses an individual’s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Gains in Patient Activation Measure (PAM®) Scores at 12 Months ... DESCRIPTION: The Patient Activation Measure (PAM) is a 10- or 13-item questionnaire that assesses an individual’s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one
Psoriasis and diabetes
Psoriasis is not just a skin disease. There is an association between psoriasis, diabetes, and excess weight, perhaps due to a common genetic cause. ... Psoriasis and diabetes ... Click to view and download the infographic. ... Download Sources: https://consumer.healthday.com/diseases-and-conditions-information-37/psoriasis-news-621/psoriasis-tied-to-obesity-type-2-diabetes-710380.html www.healio.com/news/primary-care/20160822/pcps-should-be-aware-of-potential-psoriasis-risks-treatment-options More information: Psoriasis Resource Center Help and Chat
Dermatopathology’s taste of honey
By Warren R. Heymann, MD September 2, 2020 Vol. 2, No. 35 Recently, on our consult service, my resident and I were assessing a patient with a potential autoimmune bullous disease; we concurred that a skin biopsy for routine microscopy and direct immunofluorescence (DIF) was warranted. "I’ll have to come
Plantar melanoma and mechanical stress
By Warren R. Heymann, MD June 15, 2016 Acral lentiginous melanoma (ALM) involves the palms, soles, and nail beds. It is the most common type of melanoma in patients of African or Asian descent. Delays in diagnosis result in more advanced disease at the time of diagnosis. Trauma or chronic
Pigmented onychomatricoma: Avoid getting nailed by misdiagnosis
By Warren R. Heymann, MD Dec. 2, 2020 Vol. 2, No. 47 Rightfully, monodactylous linear melanonychia should make any dermatologist nervous, with or without a Hutchinson sign. No nail unit melanoma should be left behind. ... Longitudinal melanonychia (LM) is defined as a longitudinally oriented band of brown-black pigment in
Looking beyond ‘Ozempic face’
Dermatologists weigh in on cutaneous side effects of GLP-1 agonists. ... Feature ... By Emily Margosian, Senior Editor, November 1, 2025 Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body
Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
By Warren R. Heymann, MD, FAAD April 17, 2024 Vol. 6, No. 16 Glucagon-like peptide-1 (GLP-1) receptor agonists — your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were afflicted with obesity and type
Medical research funding
Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top
Not just for boys: X-linked erythropoietic protoporphyria
By Warren R. Heymann, MD Sept. 7, 2017 I was anxiously awaiting the results of erythrocyte protoporphyrin levels obtained from a 4 year-old boy who avoids sunlight because his "skin hurts" when not in the shade. Until I read the article by Balwani, et al (1), I was unaware of
Melanoma risk in patients with melaoncortin-1 receptor independent of ultraviolet radiation: Is there a way not to be burned by your genome?
By Warren R. Heymann, MD July 18, 2016 I admit that my concept of Type I skin red-headed patients getting melanoma was simple: They have a polymorphism(s) of the melanocortin-1 receptor (MC1R), pheomelanin, ultraviolet exposure, DNA damage, increased reactive oxygen species, and voila: melanoma! While conceptually elegant, this is apparently
An old dog with a new trick: High dose intralesional steroids in hidradenitis suppurativa
By Warren R. Heymann, MD, FAAD February 2, 2022 Vol. 4, No. 5 Hidradenitis suppurativa (HS) is hitting its stride academically — deservedly so. In 2000 there were 2 publications about HS in the ... Journal of the American Academy of Dermatology ; in 2010, 9 manuscripts; and, in 2020,
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Melanoma: Tracking and Evaluation of Recurrence ... DESCRIPTION: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating provider examines and/or diagnoses the
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Melanoma: Tracking and Evaluation of Recurrence ... DESCRIPTION: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating provider examines and/or diagnoses the
2020 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... December 23 - 2020 holiday greeting December 16 - We’re in hot water! Vibrio vulnificus infections are heading north December 9 - Much ado about nothing in dermatopathology December 2 - Pigmented onychomatricoma: Avoid getting nailed by
The profound dermatological manifestations of COVID-19: Part II
By Warren R. Heymann, MD March 25, 2020 Vol. 2, No. 12 Disclaimers: This commentary was written on March 17, 2020 for a publication date of March 25, 2020. The issues related to the COVID-19 pandemic are changing like lightning. The content included in this commentary may no longer be
Transplantation dermatology: Race matters
By Warren R. Heymann, MD June 21, 2017 African American man with generalized vitiligo. Medial aspect of foot before (A) and 5 months after (B) melanocyte-keratinocyte transplantation procedure. ... Credit: ... JAAD December 3rd, 2017 will mark the 50th anniversary of the first human-to-human heart transplant performed by the late
COVID-19 can nail you in so many ways
By Elizabeth Yim, MD, MPH, FAAD, and John Montgomery Yost, MD, MPH, FAAD July 13, 2022 Vol. 4, No. 28 Dr. Elizabeth Yim and Dr. John M. Yost. ... During these difficult and quite frankly, scary times, we have heard numerous reports of various cutaneous manifestations by the SARS-COV-2 infection
Studying skin aging never gets old: The potential role of oxytocin
By Warren R. Heymann, MD Oct. 14, 2020 Vol. 2, No. 41 Every day, dermatologists address patient concerns about their aging skin — whether they are presenting for medical, surgical, or cosmetic problems. Extrinsic factors such as ultraviolet light and smoking resulting in a leathery, coarsely wrinkled appearance are well
It's the last quarter of MIPS performance year 2019: Do you have a game plan?
Answers in Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, October 1, 2019 Another performance year for the Merit Based Payment System (MIPS) program is almost over —
April 2, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 2, 2025 ... Oral vs. topical minoxidil in patients with androgenetic alopecia DermWorld Insights and Inquiries : Becoming ‘sensitized’ to the clinical utility of the term "urticarial dermatitis" (a subtype
Granulomatous slack skin: More than one type of mimicry
By Warren R. Heymann, MD November 18, 2020 Vol. 2, No. 46 My chief resident presented a case to me enamored with his clinical diagnosis of granulomatous slack skin (GSS). Although I was delighted that he considered the disorder, I explained why I thought these inguinal and submammary pink-white subtly
Metformin mania: Is it an adequate chemopreventive agent for skin cancer?
By Warren R. Heymann, MD, FAAD Aug. 31, 2022 Vol. 4, No. 35 Precisely a century ago (in 1922) metformin was synthesized, based on the folk knowledge that the active, but toxic constituent guanidine galegine, (derived from French lilac, ... Galega officinalis ) could treat "sweet urine." Metformin is now
Melanoma Reporting — Measure 397
Melanoma Reporting ... DESCRIPTION: The number of pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration, mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ... ... MEASURE ID: ... 397 ... ... Type: Process
Melanoma Reporting — Measure 397
Melanoma Reporting ... DESCRIPTION: The number of pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration, mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ... ... MEASURE ID: ... 397 ... ... Type: Process
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon – Part II – Focus on Anifrolumab
By Warren R. Heymann, MD, FAAD Sept. 13, 2023 Vol. 5, No. 37 This is an exciting time for cutaneous lupus erythematosus (CLE). Recently published findings from three clinical trials show substantial progress in developing more targeted, efficacious, and better-tolerated medications for patients with CLE, particularly by inhibiting the production
September 26
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 26, 2018 ... Drug prices spike after shortages September Access Hero: Dr. Jonathan Silverberg Dupilumab improves adolescent atopic dermatitis, quality of life Drug prices spike after shortages According to a
Low dose isotretinoin for recalcitrant rosacea: I pledge to use it sporadically
By Warren R. Heymann, MD June 14, 2016 While rosacea can usually be reasonably managed with a combination of topical agents (metronidazole, azelaic acid, ivermectin, sulfacetamide, brimonidine), oral antibiotics (the tetracycline family), vascular lasers, intense pulsed light and surgery (for phymatous disease), some cases are recalcitrant to standard therapy. ...
Adult Immunization Status — Measure 493
Adult Immunization Status ... DESCRIPTION: Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; and pneumococcal. ... ... MEASURE ID: ... 493 ... ... Type: Process
Screening for Social Drivers of Health — Measure 487
Screening for Social Drivers of Health ... DESCRIPTION: Percent of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety. ... ... MEASURE ID: ... 487 ... ... Type: Process ... ... CMS Derm Specialty Set: ...
Documentation of Current Medications in the Medical Record — Measure 130
Documentation of Current Medications in the Medical Record ... DESCRIPTION: Percentage of visits for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. ... ... MEASURE ID: ... 130 ...
Documentation of Current Medications in the Medical Record — Measure 130
Documentation of Current Medications in the Medical Record ... DESCRIPTION: Percentage of visits for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. ... ... MEASURE ID: ... 130 ...
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented — Measure 317
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented ... DESCRIPTION: Percentage of adult patients who were screened for high blood pressure and received a follow-up plan where indicated. ... ... MEASURE ID: ... 317 ... ... Type: Process ... ... CMS Derm
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Closing the Referral Loop: Receipt of Specialist Report ... DESCRIPTION: The percentage of patients with referrals during the reporting period whose referring physician received a report back from the other physician. ... ... MEASURE ID: ... 374 ... ... Type: Process ... ... CMS Derm Specialty
Key messaging in social media about acne
Key messages ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (1)
New data to recall when considering radiation recall dermatitis
By Warren R. Heymann, MD Sept. 30, 2020 Vol. 2, No. 39 I have always been mystified by the diagnosis of radiation recall dermatitis (RRD). RRD was first described in 1959 by D’Angio et al who stated: "Actinomycin D therapy alone can reactivate ‘latent’ radiation effects in normal tissues. For
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis ... DESCRIPTION: Percentage of patients with a diagnosis of severe psoriasis without a documented Body Surface Area (BSA) or a documented BSA greater than 10% for whom phototherapy or an oral systemic or biologic medication was prescribed. ... ... MEASURE ID:
Digital media kit: DermWorld print advertising
DermWorld content matters ... DermWorld provides unmatched coverage of dermatology practice issues and goes beyond the news to provide analysis and valued interpretation of what issues mean to dermatologists and their practice. We are the ... voice of dermatologists , mailing to all AAD members in the United States. ...
Do skin cancer rates differ by transplanted organ type and patient age?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, March 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Lee Wheless, MD,
Use of High-Risk Medications in Older Adults — Measure 238
Use of High-Risk Medications in Older Adults ... DESCRIPTION: Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. ... ... MEASURE ID: ... 238 ... ... Type: Process ... ... CMS Derm Specialty
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Closing the Referral Loop: Receipt of Specialist Report ... DESCRIPTION: The percentage of patients with referrals during the reporting period whose referring physician received a report back from the other physician. ... ... MEASURE ID: ... 374 ... ... Type: Process ... ... CMS Derm Specialty
Giving a NOD2 to Yao syndrome
By Warren R. Heymann, MD, FAAD March 5, 2025 Vol. 7, No. 9 The 21 ... st century has witnessed an expanding array of systemic autoinflammatory disorders (SAIDs) due to innate immunity dysfunction. SAIDs are characterized by recurrent attacks of fever, cutaneous signs, chest or abdominal pain, lymphadenopathy, vasculopathy, and
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Patient-Centered Surgical Risk Assessment and Communication ... DESCRIPTION: The percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed and discussed prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon. ...
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Patient-Centered Surgical Risk Assessment and Communication ... DESCRIPTION: The percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed and discussed prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon. ...
Adult Immunization Status — Measure 493
Adult Immunization Status ... DESCRIPTION: Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; pneumococcal; and hepatitis B. ... ... MEASURE ID: ... 493 ... ...
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis ... DESCRIPTION: Percentage of patients with a diagnosis of severe psoriasis without a documented Body Surface Area (BSA) or a documented BSA greater than 10% for whom phototherapy or an oral systemic or biologic medication was prescribed. ... ... MEASURE ID:
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Skin Cancer: Biopsy Reporting Time — Clinician to Patient ... DESCRIPTION: The percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal, squamous cell carcinoma, or melanoma (including in situ disease), or primary cutaneous malignancies who are notified of their final biopsy pathology findings within less than
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Skin Cancer: Biopsy Reporting Time — Clinician to Patient ... DESCRIPTION: The percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal, squamous cell carcinoma, or melanoma (including in situ disease), or primary cutaneous malignancies who are notified of their final biopsy pathology findings within less than
Decomplexing plexiform neurofibromas
By Warren R. Heymann, MD Dec. 29, 2016 Plexiform neurofibromas (PNs) are some of the most disfiguring and therapeutically challenging lesions that dermatologists confront. PNs are mostly associated with autosomal dominant neurofibromatosis type 1. Rarely, they may also be seen in germline p16 mutation-positive heritable melanoma and Cowden syndrome. Diffuse
The rhythm of RIME
By Warren R. Heymann, MD, FAAD March 2, 2022 Vol. 4, No. 9 Mucosal ulceration urgently gets everyone’s attention. How many times have you been asked to evaluate a patient for suspected Stevens-Johnson syndrome (SJS)? It is not always an easy task to differentiate erythema multiforme (EM) from pemphigus vulgaris,
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling ... DESCRIPTION: The percentage of adult patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months and received brief counseling if identified as an unhealthy alcohol user. ...
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling ... DESCRIPTION: The percentage of adult patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months and received brief counseling if identified as an unhealthy alcohol user. ...
Academy protects revelers’ skin at White House Fourth of July celebration
The AADA joined the White House’s Fourth of July Celebration and partnered with the White House Cancer Moonshot team to distribute AAD-branded sunscreen, lip balm, and informational flyers on sun safety and skin cancer to guests. Attendees were eager to receive sunscreen on the 90-plus degree and sunny day in
June 2, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 2, 2021 ... Acne and enthesitis: Is there an association? DermWorld Insights and Inquiries : Touching on contact pemphigus and pemphigus-like eruptions due to imiquimod Derm Coding Consult : Applying
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Melanoma: Appropriate Surgical Margins ... DESCRIPTION: Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-Melanoma (NCCN Guideline). ... ... MEASURE ID: ... AAD12 ... ... Type: Intermediate
Advance Care Plan — Measure 47
Advance Care Plan ... DESCRIPTION: Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not
Advance Care Plan — Measure 47
Advance Care Plan ... DESCRIPTION: Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes — QCDR measure AAD 20
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes ... DESCRIPTION: Percentage of adult patients (18 years old and older) who self-report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis (AK) and who self-report satisfaction with the treatment or management of AK. Patients provide a global
April 10
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 10, 2019 ... ‘Inactive’ ingredients in pills may cause allergic reaction DW Insights and Inquiries: Is there a best approach to widespread actinic keratoses? What’s the optimal way to perform
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD 17
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer, on prescribed anticoagulation therapy, who had intermediate layer and/or complex linear closures OR reconstruction after skin
U.S. medical debt hits $195 billion
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, August 1, 2022 Although 90% of the United States population possesses some form of health insurance, medical debt remains a persistent — and potentially debilitating — problem for many. Data recently released by the U.S. Census Bureau found that Americans
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Chronic Skin Conditions: Patient Reported Quality-of-Life ... DESCRIPTION: The percentage of patients aged 18 years and older with a chronic skin condition whose self-assessed quality-of-life was recorded at least once in the medical record within the measurement period. ... ... MEASURE ID: ... AAD8 ... ... Type:
Our clinical education benefits continue to grow
We offer you the updated resources you need to stay current on clinical and quality advances that optimize patient care. ... AAD Clinical Community ... Last year, we launched the AAD Clinical Community — a free, secure forum by dermatologists for dermatologists to discuss clinical issues and more. The forum
Modifier 24
Modifier 24: In a nutshell ... Used to report an E/M service performed during, but unrelated to the postoperative period of the previous procedure by the same physician. ... It’s important to know the ins and outs of this frequently used modifier. Not reporting or misusing modifier 24 can result
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Dermatitis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient reported itch severity assessments performed, score greater than or equal to 4, and who achieve a score reduction of
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Psoriasis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer who underwent intermediate layer, complex linear closure, or reconstruction after skin cancer resection in the office-based setting (not
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer who underwent intermediate layer, complex linear closure, or reconstruction after skin cancer resection in the office-based setting (not
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection — QCDR measure AAD 18
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection ... DESCRIPTION: Percentage of procedures in patients, aged 18 and older with a diagnosis of skin cancer, who had intermediate layer and/or complex linear closures OR reconstruction after skin cancer resection where opioid/narcotic therapy was prescribed as first
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Psoriasis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Dermatitis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient reported itch severity assessments performed, score greater than or equal to 4, and who achieve a score reduction of
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Skin Cancer: Biopsy Reporting Time — Pathologist to Clinician ... DESCRIPTION: The percentage of biopsies with a diagnosis of cutaneous BCC, SCC, or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within seven days from receipt of the tissue specimen. ... ... MEASURE
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Skin Cancer: Biopsy Reporting Time — Pathologist to Clinician ... DESCRIPTION: The percentage of biopsies with a diagnosis of cutaneous BCC, SCC, or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within seven days from receipt of the tissue specimen. ... ... MEASURE
Here’s looking at you, KID
By Warren R. Heymann, MD April 7, 2017 Late skin findings in lethal keratitis-ichthyosis-deafness syndrome. Intertriginous hyperkeratosis and denudation in a patient with GJB2 p.A88V mutation. ... Credit: ... JAAD Keratitis, ichthyosis, and deafness (KID) syndrome is a rare genodermatosis associated with mutations in the GJB2 gene, which encodes connexin
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months
Tofacitinib for dermatomyositis: A potential belle of the ball?
By Warren R. Heymann, MD Aug. 23, 2016 JAK1/3 signaling participates in the pathogenesis of inflammatory disorders while JAK1/2 signaling plays a role in the development of several malignancies including leukemias, lymphomas, and myeloproliferative neoplasms. Tofacitinib (Xeljans) is a pan-JAK inhibitor that is approved by the FDA for the treatment
Touching on contact pemphigus and pemphigus-like eruptions due to imiquimod
By Warren Heymann, MD June 2, 2021 Vol. 3, No. 22 Most astute medical dermatologists are aware of drug-induced pemphigus, but many (including myself) may not be as familiar with topical medications being the responsible culprits. This commentary will focus on imiquimod-induced pemphigus and pemphigus-like eruptions (PLE). ... My curiosity
When Washington, D.C., comes to you
From the President ... Dr. Thiers served as Academy president from March 2020 to March 2021. ... By Bruce Thiers, MD, November 1, 2020 If we’ve learned anything this year, it’s the importance of being flexible. For example, before COVID-19, less than 10% of our members were using telemedicine; now,
Connection to Community Service Provider — Measure 498
Connection to Community Service Provider ... DESCRIPTION: Percent of patients 18 years and older who screened positive for one or more of the following health-related social needs: food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety and had contact with a Community Service Provider for at least one
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Melanoma: Appropriate Surgical Margins ... DESCRIPTION: Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-Melanoma (NCCN Guideline). ... ... MEASURE ID: ... AAD12 ... ... Type: Intermediate
What are keratoacanthomatous lesions of the legs in mature women?
By Warren R. Heymann, MD Dec. 11, 2017 ... Right thigh, keratoacanthomatous atypical squamous proliferation. (Hematoxylin-eosin stain; original magnification: ×10.) ... Credit: ... JAAD I have an increasing number of patients asking me questions about proliferating keratoacanthoma-like lesions on their shins. "Why am I getting these? Are they cancer? Why
October 23, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 23, 2024 ... Botulinum toxin type A with topical minoxidil vs. topical minoxidil alone in males with androgenetic alopecia DermWorld Insights and Inquiries : Shocking news — Heat shock protein
Addressing systems and administrative challenges
Running a successful dermatology practice hinges not only on exceptional patient care but also on efficient administration. While challenges vary based on practice type and other factors, most practices face common administrative burdens. These burdens are a major driver of burnout. ... Surveys conducted among Academy members between 2016-2020 revealed
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Chronic Skin Conditions: Patient Reported Quality-of-Life ... DESCRIPTION: The percentage of patients aged 18 years and older with a chronic skin condition whose self-assessed quality-of-life was recorded at least once in the medical record within the measurement period. ... ... MEASURE ID: ... AAD8 ... ... Type:
Excludes notes
ICD-10 Excludes notes: In a nutshell ... ICD-10-CM codes include two sets of exclusions. ... Excludes 1 exclusions indicate when two codes cannot be billed at the same time. ... Excludes 2 exclusions indicate that the codes are separately billable. ... Excludes 1 Note ... Within the ICD-10-CM manual, you
I don’t know JAK — but I will! Ruxolitinib improving chilblain lupus erythematosus
By Warren R. Heymann, MD May 31, 2016 The JAK inhibitors are among the current darlings of treating autoimmune diseases. Recent articles about tofacitinib for vitiligo (1) and alopecia areata (2) have been reported in the lay press with considerable fanfare. ... Ruxolitinib (Jakafi) is indicated for treating intermediate to
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience — QCDR measure AAD 20
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience ... DESCRIPTION: Percentage of adult patients (age 18 years and older) who report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis. Patients provide a global assessment of the perceived effectiveness
July 11
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... JULY 11, 2018 ... Amazon upends drug market with purchase of online pharmacy Amazon recently announced it will ... purchase online pharmacy PillPack for about $1 billion. PillPack claims to simplify treatment plans for patients
PDF of AADA support letter
Honorable Lisa Murkowski The Honorable Tom Udall Chairman Ranking Member Subcommittee on Interior
September 2, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 2, 2020 ... What role can dermatologists play in developing a COVID-19 vaccine? DW Insights and Inquiries : Dermatopathology’s taste of honey Non-discrimination protections change under ACA Skin of color
August 2, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 2, 2023 ... Isotretinoin for seborrheic dermatitis: A review DermWorld Insights and Inquiries : Cellular neurothekeoma: A tribute to Barnhill and Mihm and a remembrance of Martin C. Mihm Jr.,
July 2, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 2, 2025 ... Isotretinoin for seborrheic dermatitis DermWorld Insights and Inquiries : Turning our attention to melanoma risk in Turner syndrome CMS updates MUE limit for Ameluz — Effective July
Compounding toolkit
Can you compound or prescribe it? ... Answer a few questions below to determine whether the type of compounding you are performing is in compliance with Food & Drug Administration (FDA) regulations and how to access the drug product if it cannot be compounded in your office. ... Are you
February 2, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 2, 2022 ... A high-fiber diet may affect immunotherapy response for melanoma patients DermWorld Insights and Inquiries : An old dog with a new trick — High dose intralesional steroids
New treatments provide more options for people with alopecia areata
Journal of the American Academy of Dermatology ... article highlights new ways to restore hair ROSEMONT, Ill. (Aug. 15, 2023) — A study published today in a supplement of the ... Journal of the American Academy of Dermatology titled " ... Alopecia: A New Frontier " reveals that a new
November 2, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 2, 2022 ... Factors that influence platelet rich plasma efficacy in androgenetic alopecia DermWorld Insights and Inquiries : Lipodystrophia semicircularis — A lipoatrophy not to get depressed about Underlying conditions
New study reveals that some children with common form of eczema should also be tested for allergic reactions
Study author highlights test used to differentiate between two types of eczema ROSEMONT, Ill. (September 26, 2023) — Eczema, which is a group of medical conditions that causes inflamed, irritated, and often itchy skin, affects millions of people worldwide. A new article published in the ... Journal of the American
October 2, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 2, 2024 ... Risk of IBD in patients receiving isotretinoin DermWorld Insights and Inquiries : The pregnant pause in cutaneous lymphoma Hydroxychloroquine in patients with lichen sclerosus Abrocitinib vs. dupilumab
Coding and documentation clarity
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, April 2, 2018 You biopsy a suspected drug eruption and document the following: "Punch biopsy done. Return in 1
December 2, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 2, 2020 ... Surgical vs non-surgical interventions for basal cell carcinoma DermWorld Insights and Inquiries : Pigmented onychomatricoma — Avoid getting nailed by misdiagnosis Derm Coding Consult : Coding for
Putting care into context
Considerations for navigating social drivers of health in general and pediatric dermatology. ... Feature ... By Emily Margosian, Senior Editor, January 1, 2026 A hot shower, reliable transportation, private living space. More than just everyday needs, these factors can have a serious impact on individual health. ... Literature suggests social,
March 2, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 2, 2022 ... Biotin beware: Physician, patient knowledge about lab interference DermWorld Insights and Inquiries : The rhythm of RIME Infections in children treated with dupilumab Cutaneous adverse events are
We’ve gotta recognize GATA2 deficiency
Cutaneous findings in GATA2 deficiency. (A) Extensive human papillomavirus infection with vulvar and anal intraepithelial neoplasia, (B) cutaneous mycobacterial infection, and (C) erythema nodosum–like panniculitis in a 40-year-old woman with GATA2 deficiency. ... Credit: ... JAAD By Warren R. Heymann, MD Dec. 26, 2018 I’ll begin with my conclusion —
Components of evaluation and management 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, June 1, 2018 Test your knowledge: Components of evaluation and management 2 ... Take the quiz to see if
Treatments for renal IgA vasculitis are beginning to flow
By Warren R. Heymann, MD, FAAD Feb. 19, 2025 Vol. 7, No. 7 The alliterative phrase "palpable purpura" will instantly conjure the diagnosis of leukocytoclastic vasculitis (LCV) for dermatologists. IgA vasculitis (IgAV, aka Henoch-Schönlein purpura [HSP]) is the most common vasculitis in children but is much less frequent in adults.
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with
Appropriate Documentation and Shared Decision Making of AK — QCDR measure AAD 21
Actinic Keratosis: Appropriate Documentation and Shared Decision Making of AK ... DESCRIPTION: Percentage of adult patients (18 years old and older) diagnosed with Actinic Keratosis (AK) whose healthcare provider has recorded the following information in the patient’s medical record 1) documentation of the number or range of AKs, 2) location(s)
Biopsy coding in 2019: Part 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, December 3, 2018 Test your knowledge: Biopsy coding in 2019 — Part 2 ... Take the quiz to see
RAC audits: Target areas
This page has quick tips, facts, and links for you to keep on hand so that you can stay on top of the audit game. ... Where a RAC will catch you ... It goes without saying that you must be careful about many procedures when you’re a physician. However,
Evaluation and management in 2021: Part 2
Cracking the code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, October 1, 2020 Test your knowledge: Evaluation and management in 2021: Part 2 ... Take the quiz to see
Chanarin-Dorfman syndrome: Shifting out of neutral
By Warren R. Heymann, MD, FAAD Aug. 27, 2025 Vol. 7, No. 34 In nearly all neutrophil, eosinophil and basophil leukocytes and in the monocytes, several clear vacuoles of varying size were observed in the cytoplasm, which after vital staining…revealed a red colour, i.e. contained a fatty substance. The erythrocytes
Being there
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... DW Weekly talked to Diana Bartenstein, MD, a PGY-2 dermatology resident at Massachusetts General Hospital, about her work as a responding clinician on an inpatient COVID-19 ward. For too many COVID-19 patients, the end has
Vascular Ehlers-Danlos syndrome: From rupture to rapture?
By Warren R. Heymann, MD, FAAD February 16, 2022 Vol. 4, No. 7 If there was a statistic for a dermatological diagnostic impact factor, vascular Ehlers-Danlos syndrome (vEDS) would be at the top. Often undiagnosed until tragedy strikes, astute dermatologists who consider the diagnosis prior to an acute event may
CPT 2018: What's new, part 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, January 1, 2018 Test your knowledge – CPT 2018: What's new, part 2 ... Take the quiz to see
Triskaidekaphobia legitimized: Fatal Factor XIII deficiency
By Warren R. Heymann, MD, FAAD April 12, 2023 Vol. 5, No. 15 I am not especially superstitious. The number 13 has never concerned me but acquired Factor XIII deficiency has now joined my ever-expanding pantheon of new complications to worry about. ... The article entitled "Association of lethal acquired
Caveat mTOR revisited: Neurofibromatosis
By Warren R. Heymann, MD, FAAD Feb. 14, 2024 Vol. 6, No. 7 An abridged version of this commentary was published in "A Clinician's Perspective" in the April 2023 issue of the JAAD. ... It is understandable how dermatologists may forget about many details of rare genodermatoses after taking their
Unrestricted fascination with restrictive dermopathy
By Warren R. Heymann, MD, FAAD Nov. 16, 2022 Vol. 4, No. 46 Barely a week into our fellowships at the University of Pennsylvania in 1984, my wife (a geneticist) asked her favorite dermatologist (me) if I had any thoughts about a neonate with skin that was thin, taut, and
Stress^2 + Hormones^2 = Acne^2
By Warren R. Heymann, MD June 5, 2019 Vol. 1, Issue 13 I would wager that every human being has experienced at least one pimple attributed to stress. I recall a devastatingly embarrassing moment during 10th grade world history class at Martin Van Buren High School (Queens, New York), when
Waiting for Wong
By Warren R. Heymann, MD ... Oct. 6, 2016 ... The Wong variant of dermatomyositis was originally described by O’Leary during the Eisenhower administration (1953) and named for Wong during Nixon’s tenure (1969). I have been involved with dermatology since Carter’s term in office (1979). Since that time (Reagan,
Tressed to impress: tips for keeping your mane magnificent
6 tips for healthier looking and feeling hair from a board-certified dermatologist ROSEMONT, Ill. (Aug. 13, 2024) — Hair is as unique as its wearer, making care an important aspect in one’s overall health and wellness routine. From understanding your hair type to learning the best shampooing technique (yes, there
Not aging like fine wine: The myths and mysteries of acquired port wine stains
By Warren R. Heymann, MD January 13, 2021 Vol. 3, No. 2 Port wine stains (PWS, aka nevus flammeus, nevus simplex, salmon patch) are cutaneous capillary malformations that are characteristically congenital (CPWS) but may be acquired (APWS). APWS was first described in a German publication by Fegeler in 1949, hence
IA25 Meeting Suites Guidelines
charge to be billed directly through Freeman: • exterior graphic panel to the right of the door • Interior
Intermediate and complex repairs 2020: Part 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, November 1, 2019 Intermediate and complex repairs 2020: Part 2 ... Take the quiz to see if you're up
Topical crisaborole ointment for atopic dermatitis: Hoping for a painless introduction
By Warren R. Heymann, MD Aug. 13, 2016 Any dermatologist who treats atopic dermatitis (AD) must be eagerly awaiting the introduction of 2% Crisaborole ointment. This is equally true for patients (and their parents!) who are steroid-phobic and uncomfortable with the black box warning for calcineurin inhibitors (despite our reassurances).
2025 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines
to be billed directly through Freeman: • (1) exterior graphic panel to the right of the door • Interior
What is the minimum I need to report to meet the MIPS threshold in 2019?
Asked and Answered ... February 1, 2019 If you or your practice must participate in the Merit-based Incentive Payment System (MIPS) for 2019 and want to simply avoid the ... 7% penalty (penalty applied in 2021), the ... minimum score to avoid the penalty is 30 points — up from
'Stepping up' to off-label dosing of biologics
By David A. Wetter, MD, FAAD April 6, 2022 Vol. 4, No. 14 It is an exciting time to be a medical dermatologist, with the ongoing development of numerous safe and effective systemic treatments for several complex medical dermatologic diseases. For example, both the American and British guidelines for the
AESOP: The ants and the grasshopper
By Warren R. Heymann, MD, FAAD Aug. 21, 2024 Vol. 6, No. 34 Unquestionably, AESOP ( ... A denopathy and ... E xtensive ... S kin patch ... O verlying a ... P lasmactyoma) is rare — to date, fewer than 25 cases have been reported. (1) Why write (or
Becoming pro-geriatric by understanding progeria
By Warren R. Heymann, MD Aug. 13, 2018 A fifteen-year-old boy with Hutchinson-Gilford progeria syndrome. ... Credit: ... JAAD I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely
2026 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines
to be billed directly through Freeman: • (1) Exterior graphic panel to the right of the door • Interior
Paraneoplastic syndromes (PNS) associated with merkel cell carcinoma are analogous to small cell cung Cancer: A comparison to other lung cancers
By Warren R. Heymann, MD Sept. 2, 2016 Merkel cell carcinomas (MCC) are neuroendocrine tumors associated with the Merkel cell carcinoma polyomavirus in >80% of tumors (1). Small cell lung cancer, another neuroendocrine tumor, is associated with paraneoplastic syndromes (PNS) in up to 20% of cases, notably the syndrome of
Tarrying for tapinarof
By Warren R. Heymann, MD, FAAD January 12, 2022 Vol. 4, No. 2 Today we held our first round of interviews for our dermatology residency program for 2023. Meeting dermatology resident applicants is a delight — they are brilliant, engaging, and a source of pride for our discipline. We started
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy ... DESCRIPTION: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month
Dermatology antibiotic prescription trends
Facts at your fingertips ... By Emily Margosian, assistant editor, November 1, 2019 As antibiotic resistance has increasingly captured the attention of the media and global health organizations, physicians have found themselves under more pressure to monitor their antibiotic prescription habits. Although overall antibiotic prescribing by dermatologists decreased by 36.6%
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy ... DESCRIPTION: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month
Key messages in social media about eczema
Key messages ... Eczema refers to a group of conditions that lead to inflamed skin. Signs of inflamed skin include a rash, itchiness, and excessive dryness. (1) ... There are several types of eczema. Atopic dermatitis is the most common type. ... Eczema is a complex condition. Your genes, immune
Atrophic tinea versicolor: Knowledge about its pathogenesis is hypertrophying
By Warren R. Heymann, MD April 12, 2017 In the entry "Atrophic Tinea Versicolor: More Than a Mirage" (April 22, 2016), I learned that the atrophic appearance of some cases of tinea versicolor is not just an optical illusion. The case of a 35-year-old man with depressed brown lesions on
AAD membership at a glance
Facts at your Fingertips ... By Emily Margosian, content specialist, June 1, 2018 Which way are the winds of dermatology blowing? AAD membership data may serve as a bellwether. In 2018, overall membership surpassed 20,000 dermatologists, but beyond hitting the 20K mark, other demographic changes regarding gender and practice type
The retiring type?
By Warren R. Heymann, MD April 23, 2017 "Tell me, Dr. Heymann, when do you plan to retire?" ... Patients seem to ask me that every day. ... My usual response: "Why do you ask, do I look that bad?" ... "No, you look pretty good for your age." (According
Becoming “sensitized” to the clinical utility of the term “urticarial dermatitis” (a subtype of the dermal hypersensitivity reaction pattern)
By David A. Wetter, MD, FAAD April 2, 2025 Vol. 7, No. 13 I suspect many of us have been confounded when confronted with a patient presenting with cutaneous findings suggestive of a "dermal hypersensitivity reaction." What is the cause? How should it be evaluated and treated? What do we
Small group practice (6-15 practitioners)
Best for: Dermatologists seeking clinical autonomy, peer collaboration, and work-life balance without solo ownership responsibilities. ... Quick summary: Join a privately owned dermatology group with a small number of physician partners. It offers more control than you’ll find in large settings, but also more help than a solo practice. A
Platelet rich plasma: Good for whatever ails you?
By Warren R. Heymann, MD Jan. 13, 2017 Hair regrowth in ophiasis-type alopecia areata after platelet-rich plasma (PRP) injection. Occipital hair loss before treatment (A) and occipital hair regrowth 3 months after administration of PRP at a concentration 3.5 times above baseline (B). ... Credit: ... JAAD Okay, okay, I
Thoughts on hyaluronidase and The House of God
By Warren R. Heymann, MD January 15, 2020 Vol. 2, No. 2 I was reminiscing about my internship at Bellevue-NYU forty years ago after reading Stephen Bergman’s (pseudonym Samuel Shem) reflections on the fortieth anniversary of his irreverent, but hilariously accurate, ... The House of God — a portrayal of
Reporting Quality for MIPS
The tracking of quality measures and the implementation of improvement activities can help to lead to improved outcomes in patient care and care processes. ... Quality measures ... AAD continues to expand the number and type of dermatology-specific measures for reporting to CMS. Access a complete list of MIPS measures
January 30
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / January 30, 2019 ... Dermatologists prescribe fewer antibiotics overall, but use increased with surgery CMS updates Open Payments data What causes allergic responses in patients with atopic dermatitis? YouTube videos about
Applying the 2021 E/M coding concepts in everyday practice – Part 3
Part three of the AADA’s clinical vignettes focuses on the application of the more challenging concepts related to the review and analysis of data in the AMA Medical Decision-Making table. Understanding the application of these concepts will assist you in determining when data may impact the level of service provided.
The concept of atrophoderma of pasini and pierini as morphea may be falling off a cliff
By Warren R. Heymann, MD Nov. 6, 2017 ... Clinical photos of idiopathic atrophoderma of Pierini and Pasini. ... Credit: ... JAAD Diagnosing Atrophoderma of Pasini and Pierini (APP) is reasonably straightforward — it usually presents in adolescents and young adults, more often in females, with sharply defined, single or
Advocating for you — Preventing Medicare cuts
Persistence keeps Medicare cuts at bay ... Medicare is front and center again as we build on last year’s win, successfully fending off physician payment cuts due to the Medicare sequester during the COVID-19 public health emergency. After the moratorium on the regular 2% Medicare payment cuts was extended through
This month’s news from across the specialty
What’s hot ... August 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Maureen Offiah, MD, FAAD Several physician groups have recently modified the ... staging and classification of all primary cutaneous lymphomas (PCL). Changes to
CBD: Potential or placebo?
Go to AAD Home ... Go to AAD Home ... Menu ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... By Emily Margosian, assistant editor This recent Mother’s Day holiday, shoppers may have observed
My fair-weather therapeutic friends for alopecia areata
By Warren R. Heymann, MD April 25, 2017 Type C clinical pattern of alopecia. A, Patchy hair loss on a background of a diffuse hair loss with (B) occipital involvement in an ophiasis-like pattern. C, Biopsy specimen obtained from the vertex of the scalp. Histopathology of vertical sections shows an
Atopic dermatitis hide and seek: The impending role of OX40 inhibition
By Warren R. Heymann, MD, FAAD Sept. 11, 2024 Vol. 6, No. 37 The burden of atopic dermatitis (AD) — for patients, their families, and society — is vast and increasing. AD affects approximately 10% to 30% of children and 2% to 10% of adults in developed countries. (1) Aside
Alleviate the ouch
Experts share best practices and review the latest on safety concerns for anesthesia use in children. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2024 Use of anesthesia can be tricky in adults, but even trickier in children. The use of local or general anesthesia in pediatric dermatology
The Term “Dermal Hyperneury” Hits a Nerve
By Warren R. Heymann, MD Dec. 21, 2017 ... A, On hematoxylin-eosin stain, the borders of this nerve bundle are sharply demarcated from the surrounding connective tissue with no associated inflammation or fibrosis. A thin layer of epithelium can be seen encapsulating the intersecting fascicles of nerve fibers. Within the
Contract reimbursement review
When deciding whether to sign a contract with a payer, reimbursement is one of the most important considerations. Adequate reimbursement is critical to the viability of your practice. Therefore, be sure to review contract language on reimbursement carefully. ... Aspects of reimbursement are often negotiable, though the extent to which
Digital media kit: DermWorld editorial calendar
Download a PDF of the 2026 DermWorld editorial calendar . ... JANUARY ... FEBRUARY ... MARCH ... Preparing derms to use ... GLP-1 RA Coding: Soft tissue excision ... Managing declining morale in health care ... Close: 11/25/25 ... Materials due: 12/3/25 ... Mail date: 1/2/26 ... Update on ...
Eye-opening news about oxymetazoline
By Warren R. Heymann, MD, FAAD April 27, 2022 Vol. 4, No. 17 Certain articles have a "wow" factor that immediately impacts practice. In 2007, I recall being impressed by the 2 cases of erythematotelangiectatic rosacea reported by Shanler and Ondo that dramatically improved with the application of oxymetazoline hydrochloride
Tennessee legislation increases transparency
Tennessee Gov. Bill Lee (R) signed legislation limiting the use of medical specialty titles in advertisements. ... The new state law requires any advertisement for health care services to include the name of a health care practitioner and the type of licensure or profession held. The AADA believes that all
A dermatologic riddle: How is IgG4-related ophthalmic disease parliamentary?
By Warren R. Heymann, MD March 22, 2017 Immunostains of infiltrate. A, Immunostain shows an infiltrate rich in IgG4+ plasma cells. The infiltrate had an IgG4+ cell count of 80 per HPF and an IgG4+/IgG+ ratio of 80%. B, IgG immunostain shown for comparison. (A and B, original magnifications:
What to expect for MIPS 2024
Answers in Practice ... By Olivia Barry, Manager, Practice Management, April 1, 2024 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff explains what to expect for MIPS 2024. On Nov. 2, 2023, CMS released the final Quality Payment Program (QPP) Rule which includes
Working up pernio: How far should you dip your toe in the water?
By David A. Wetter, MD May 6, 2020 Vol. 2, No. 18 Dermatologists are rapidly becoming reacquainted with pernio (chilblains), given the increasing reports of pernio-like acral eruptions (and other dermatologic manifestations) occurring in association with COVID-19. (1, 2) This raises an important clinical question: under normal (non-COVID-19) circumstances, what
A Trumpian analysis of infliximab-induced follicular mucinosis: Something’s going on here
By Warren R. Heymann, MD July 10, 2016 Williams et al presented two cases of biopsy-proven facial follicular mucinosis (FM), apparently induced by infliximab, with a normal tissue CD4/CD8 ratio of 2/1 and the presence of CD7, thereby ruling out CTCL. The first case was a 23 year-old man with
June 5
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 5, 2019 ... Self-injection of black market dermal fillers poses health concern DW Insights and Inquiries : Stress 2 ... + Hormones 2 ... = Acne 2 ... CMS/NCCI announce
Tofacitinib for adolescent alopecia areata: Balancing the risk-benefit ratio
By Warren R. Heymann, MD Jan. 17, 2017 Alopecia areata with patient 4 after 2 months of treatment with 2% tofacitinib in VersaBase cream (A) and after 6 months of treatment with 2% tofacitinib in liposomal base (B). ... Credit: ... JAAD There has been acute interest in utilizing Janus
What's hot?
What's hot ... February 26, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Isn’t it interesting how some common warts that we treat seem to go away almost instantly but others persist
Learning module: Genetic skin diseases
Goals and objectives ... The purpose of this module is to help develop a clinical approach to the evaluation and initial management of patients presenting with genodermatoses. ... By completing this module, the learner will be able to: ... Identify and describe the morphology of skin lesions typical of tuberous
Malpractice insurance 101
Experts offer advice on navigating malpractice insurance policies. ... Feature ... By Andrea Niermeier, Contributing Writer, February 1, 2025 While medical malpractice suits first regularly appeared in the United States in the 1800s, the frequency of claims has only increased since the 1960s, with lawsuits relatively common today. Medical malpractice
March
Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I always knew firefighting was a dangerous occupation What’s hot ... This month’s news from across the specialty Clinical Applications ... Do skin cancer
Move over Lues: Graft-versus-host disease is the new mimicker king
By Warren R. Heymann, MD May 9, 2016 I have always been intrigued by graft-versus-host disease (GVH). I first learned of the disorder in my college immunology course when it was referred to as a cause of "runting syndrome" in mice. ... In the context of transplant recipients, classical features
Necrobiosis lipoidica in a Wink
By Warren R. Heymann, MD, FAAD May 3, 2023 Vol. 5, No. 18 Ninety years have transpired since Urbach coined the term ... necrobiosis lipoidica diabeticorum (NLD) for the granulomatous disorder first described by Oppenheim in 1929 as ... dermatitis atrophicans lipoidica diabetica . (1) Early authors observed sclerotic plaques
The doctor will see you...soon?
Facts at your Fingertips ... By Emily Margosian, assistant editor, July 1, 2019 As efforts to improve access to dermatologic care remain ongoing (Read ... Dermatology World ’s 2017 feature "Access Granted" at ... www.aad.org/dw/monthly/2017/october/access-granted for strategies to broaden patient access), how long can the average patient expect to wait
AAD Event Advertising: Annual Meeting
The Academy's Annual scientific meeting offers unprecedented access to thousands of dermatologists attending high-profile continuing medical education events. ... For exhibitors looking to promote their products and services, build booth traffic, and facilitate face-to-face discussions, the Academy offers a wide selection of high-impact advertising opportunities. Look here for advertising opportunities
Understanding the risk of Wilms Tumor in hemihypertrophy: Are we halfway there?
By Warren R. Heymann, MD Nov. 16, 2017 ... Diffuse capillary malformation with overgrowth. A 2-month-old girl with ill-defined erythematous patches of the bilateral upper extremities, posterior trunk, and left lower extremity. There is also overgrowth of the left lower extremity. ... Credit: ... JAAD Wilms tumor (WT, nephroblastoma) is
Mohs Surgery Appropriate Use Criteria (AUC) app
There are many considerations when determining whether to use Mohs surgery for the treatment of skin cancer, such as the cancer type, location, and whether it is new or recurring, as well as the health profile of the patient. ... With the Academy's complimentary Mohs Surgery Appropriate Use Criteria (AUC)
Trichophyton rubrum resistant to terbinafine
Trichophyton rubrum resistant to terbinafine ... T. rubrum , a dermatophyte fungus, is the most common cause of dermatophytosis worldwide. ... 1 ... Oral terbinafine is considered a first-line treatment for most infections caused by this fungus, but cases of terbinafine-resistant ... T. rubrum are increasingly being reported worldwide and
Vulvar hidradenoma papilliferum and mammary-like gnogenital glands: The whole story
By Warren R. Heymann, MD July 31, 2016 I had always assumed that hidradenoma papilliferum (HP), which characteristically appears in the vulvar region, was derived from apocrine glands. Until I read the article by El-Khoury et al (1) I had never even heard of mammary-like anogenital glands (MLAGs). ... Although
Private payer appeal letter tool
How can I appeal insurance denials? ... Use the tool below to generate letters from automated templates. These letter templates are intended to help dermatologists appeal to private payers when payments are inappropriately reduced. They may be modified to specifically address your circumstances and those of your patients. ... {{
Why you should hear about the red ear syndrome
By Warren R. Heymann, MD July 22, 2020 Vol. 2, No. 29 Is it my imagination that the "by the way" comments at the presumed end of a patient encounter cause the most angst? Usually, it’s something like "Oh, I forgot to mention that I’m losing my hair!" Recently, at
Ransomware attacks on U.S. health care double
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, February 1, 2024 Ransomware is on the rise. A recent ... JAMA Health Forum study found that the annual number of ransomware attacks on health care organizations more than doubled from 2016 to 2021, exposing the personal health information (PHI)
Demand for cosmetic procedures resumes after COVID
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, April 1, 2023 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions due to the ebb and flow in national and regional caseloads. ... The release of new
Melanoma incidence rising, deaths decreasing
Facts at your fingertips ... By Emily Margosian, assistant editor, December 1, 2019 According to data from the National Institutes of Health (NIH) Surveillance, Epidemiology, and End Results Program (SEER), there were an estimated 96,480 new cases of melanoma of the skin in 2019 — making it the fifth most
Dermatologic care is critical as patients age
A timely surgery in a dermatologist’s office removes a patient’s skin cancer. ... Karen's story ... Skin cancer is frightening, especially when it appears in the middle of your face. ... As a survivor of other skin cancers, I’m glad my dermatologist Dr. Terrence Cronin, Jr. quickly examined a raised,
Improvement activities (15%)
In this performance category, clinicians are rewarded for care focused on care coordination, beneficiary engagement, and patient safety. For 2025 MIPS reporting, this category is worth 15% of the MIPS score with a maximum of 40 points available. There are 77 dermatology-relevant practice improvement activities (IAs) to choose from. ...
COVID’s impact on cosmetic procedures
Facts at your fingertips ... By Emily Margosian, Assistant Editor, April 1, 2022 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions throughout the year due to the ebb and flow in national and regional caseloads. The release
LIDA* rose the insulin requirement
By Warren R. Heymann, MD April 14, 2021 Vol. 3, No. 15 * Localized insulin-derived amyloidosis ... Amyloidosis, I thought I knew ye. But alas, you fooled me again. ... Amyloid is an insoluble protein folded in ... β -pleated sheets that is deposited extracellularly. Amyloid can accumulate in one
Providing relief to a child with rare blood vessel growth
A dermatologist helps a young boy get relief from a painful blood vessel condition. ... Jenna Buswell's story ... Casen Buswell, patient ... My son Casen was born with purple spots on most of his body that left doctors stumped. My husband and I were terrified as he was whisked
Specialties collaborate to create an effective treatment plan
A dermatologist and hematologist/oncologist keep a patient’s rare lymphoma in remission. ... Victoria’s story ... Victoria Perez – Phoenix, AZ ... For six years I had discolored spots that looked like bruises across my body—on my arms, legs, abdomen and buttocks. I knew something was off, but didn’t get a
Life insurance 102: Five success factors when using permanent life insurance
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 2, 2019 In
Reporting excimer laser therapy: When to use 96999 vs 9692x
As a result of a code descriptor change for CPT codes 96920-96922 effective Jan. 1, 2024, these codes are now to be used only for excimer laser treatment of psoriasis. This change was made by the AMA CPT to better align with the intended use of these services exclusively for
Working together to provide optimal melanoma care
Medical, surgical, and radiation oncology; dermatology; and other specialties collaborate to improve skin cancer treatment. ... Dr. Albertini's story ... Mark R. Albertini, MD, Oncologist, University of Wisconsin School of Medicine and Public Health ... The melanoma tumor board at the University of Wisconsin School of Medicine and Public Health
Early diagnosis catches scarring condition
A dermatologist’s quick action helps a patient with alopecia regain her confidence. ... Julie's story ... Julie Wright, patient ... Like a lot of parents, my two kids keep me very busy, so I put taking care of myself on the back burner. However, I knew I needed to take
Yom Kippur and the physician payment Sunshine Act
By Warren R. Heymann, MD Oct. 9, 2016 Yom Kippur, the Jewish day of atonement, is upon us. It is Judaism’s most sacred holiday. It is a day of fasting and prayer to atone for sins of the past year. According to traditional teachings, a person’s fate is written in
Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis
By Warren R. Heymann, MD, FAAD Oct. 16, 2024 Vol. 6, No. 42 Atopic dermatitis (AD) is characterized by skin barrier dysfunction, inflammation, and chronic pruritus. The etiology of AD, however, is complicated and incompletely understood, with genetic, environmental (soaps, surfactants, stress), and immunological factors causing skin barrier abnormalities and
Key messages for social media about hair loss
Key messages ... Many conditions and diseases can result in hair loss, as can improper hair care. ... The most common cause of hair loss is hereditary thinning or baldness, also known as androgenetic alopecia. (1) This condition affects an estimated 80 million Americans — 50 million men and 30
Teledermatology workflow for small practices
Use the workflow below to help you implement or improve your teledermatology operations. This version is designed for solo or small practices. There is a distinct PDF guide for dermatologists who practice in an ... academic or multispecialty organization . ... 1. Technology setup ... Create a generic account on
Practice types in dermatology
Dermatologists can choose from a diversity of practice types, from independent to group and institutional. Each of these practice types comes with trade-offs between between autonomy and support, benefits and risks. There are also new practice models, meant to improve value and contain costs. Use the AAD resources below to
Striving to alleviate the physical and emotional scars of central centrifugal cicatricial alopecia
By Warren R. Heymann, MD November 4, 2020 Vol. 2, No. 44 More than half a century ago, Drs. Lopresti, Papa, and Kligman coined the term "hot comb alopecia," asserting: "The cause is unmistakable, namely the practice of straightening the hair with a hot comb…" (1). Now known as central
PDF of Oral disease, part 2
boards’ fodder #1 Oral Disease, Part 2 by Helena Pasieka, MD CLINICAL PATHOLOGY TREATMENT ASSOCIATIONS
Advocacy Update Feb 3, 2026
IN THIS ISSUE / Feb. 3, 2026 Dermatologists urged Washington state to support truth in advertising Humana corrects destruction code denials Academy asks CMS to reduce regulatory burdens on dermatology Contribute to SkinPAC Truth in Advertising Dermatologists urged Washington state to support truth in advertising ... The AADA ... urged
Trichophyton indotineae infections and other severe or antifungal-resistant dermatophytoses
Dermatophytosis (ringworm, tinea, jock itch, athlete’s foot) is a very common and typically minor infection of the skin caused by dermatophyte fungi. ... 1 ... In the past decade, severe or antifungal-resistant dermatophytoses have become a global public health concern, including in the United States. ... The AAD has assembled
4 cradle cap tips from dermatologists
Tips from board-certified dermatologists ROSEMONT, Ill. (August 18, 2022) — Bringing home a new baby is a joyous time for any parent. For first time parents, bringing home a new baby can unlock a wide range of emotions—from excitement to nervousness. As you adjust to parenthood, you’ll notice that your
Sirolumus’s merit for the Kasabach-Merritt phenomenon
By Warren R. Heymann, MD Oct. 8, 2018 KHE patient after 15 months of sirolimus therapy. ... Credit: ... JAAD Thrombopenic purpura associated with benign hemangioma is rare. In fact, we have not been able to find a record of a combination of these two conditions in the medical literature.
Recognizing Trichophyton indotineae
Reporting to health departments ... Physicians who suspect antimicrobial-resistant dermatophytosis can also contact ... their state or local health departments for assistance . Public health officials who are concerned about potential cases or clusters of drug-resistant tinea infections can email ... fungaloutbreaks@cdc.gov for assistance with recommendations and testing. ... Overview
How to prevent keloid scars
Board-certified dermatologist shares tips to reduce your risk ROSEMONT, Ill. (Dec. 6, 2023) — Keloids are a type of raised scar that can occur after an injury, and over time they can grow much larger than the wound itself. Although keloids are not dangerous to a person’s health, they can
AAD's guidance on resources related to workplace violence
Unfortunately, violence in the workplace has become more common in health care and incidences are slowly rising. Has someone at your dermatology practice ever experienced any type of violence at work? Is your practice equipped or prepared to handle violence, if it were to occur? Dermatologists are not always trained
Intralesional triamcinolone for hidradenitis suppurativa and thoughts on confirmation bias
By Warren R. Heymann, MD Dec. 2, 2016 Anyone who has treated the scourge of hidradenitis suppurativa (HS) has probably injected inflamed nodules and cysts with triamcinolone (TAC) successfully, resulting in very grateful patients. Despite the useful advent of adalimumab to the other (less than satisfactory) modalities of antibiotics,
Sézary syndrome and Shakespeare: What’s in a name?
By Warren R. Heymann, MD ... March 24, 2017 ... Initial clinical presentations of Sézary syndrome without erythroderma. Normal-appearing skin with moderate pigmentation on back of patient 2 (A), several seborrheic keratoses and a hematoma secondary to skin biopsy for patient 3 (B), no apparent lesion on back of
The congenital perineal groove: Defective recognition of a dermal defect
By Warren R. Heymann, MD ... Feb. 28, 2018 ... It has been nearly half a century since Stephens first detailed the perineal groove (PG) as a congenital malformation consisting of three features: (1) a wet groove in the midperineum between the fourchette and the anus; (2) normal formation of
Spot on! Lentigines in resolved psoriatic plaques
By Warren R. Heymann, MD Nov. 30, 2016 Having treated psoriatic patients throughout my career, there have been innumerable occasions where patients were concerned about pigmentary changes following successful treatment of the plaques. I have usually reassured them that these are postinflammatory pigmentary alterations that should abate with time. Recently,
Dupilumab treatment of bullous pemphigoid: Hoping for approval on the double
By Warren R. Heymann, MD, FAAD Jan. 15, 2025 Vol. 7, No. 2 Perhaps dupilumab won’t be the game-changing biologic that patients are pining for. At the least, it represents the dawn of the biologic era for AD [atopic dermatitis] ... . That alone offers hope for our long-suffering patients,
On the cusp of extraordinary advances in extramammary Paget disease
By Warren R. Heymann, MD May 27, 2020 Vol. 2, No. 21 I always include extramammary Paget disease (EMPD) and Bowen disease in my differential diagnosis of anogenital rashes for fear of missing them. It is good form to biopsy such lesions should they not respond to standard therapies for
CMS creates permanent drug code for treating molluscum contagiosum
Last updated: March 5, 2026 ... CMS has created a permanent drug code, J7354, for cantharidin, a drug used to treat molluscum contagiosum in adult and pediatric patients 2 years and older. The new J-code became effective on April 1, 2024. ... Cantharidin is the first ... FDA-approved topical treatment
What is the status of MAC implementation of the NCCI new procedure to procedure edits for the new biopsy codes?
Asked and Answered ... August 1, 2019 As of July 1, 2019, service modifiers 59 and XE, XS, XP, and XU may be appended to either Column 1 or Column 2 codes in the National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) edits table, when appropriate. On March 29, the Centers
Raising a toast to advances in treating alcohol-induced flushing
By Warren R. Heymann, MD November 11, 2020 Vol. 2, No. 45 Whether with pride or embarrassment, we have all blushed. Also known as flushing, the process is defined as a visible reddening of the skin accompanied by a sensation of warmth, characteristically affecting the face, ears, neck, and upper
Here comes the sun: The role of polypodium leucotomos extract
By Warren R. Heymann, MD Aug. 9, 2017 Ultraviolet (UV)B response. Changes in biomarkers of UV radiation exposure before and after Polypodium leucotomos extract (PLE). A, Stained nuclei for cyclobutane pyrimidine dimers (CPD), Ki67, proliferating cell nuclear antigen (PCNA), and cyclin D1. B, Sunburn cells and cytoplasmic staining for cyclooxygenase-2
Getting within a hair’s breadth of understanding prurigo pigmentosa
By Warren R. Heymann, MD March 2, 2017 Prurigo pigmentosa is an uncommon, acquired inflammatory disorder with a predilection for young adults of Asian descent. A 30-year-old Chinese man presented with reticulated erythematous and hyperpigmented papules on his back and shoulders (A and B). The eruption was present for 2
Psoriasiform eruptions during Kawasaki disease (KD): A prognosis that lets the good times roll
By Warren R. Heymann, MD June 27, 2016 Psoriasiform skin changes have been rarely described in the literature in both acute (1-4 weeks) and convalescent phases (4-12 weeks) of KD (1). ... Haddock et al, in their review of 870 cases of KD, identified 11 patients with a psoriasiform eruption
Moving the needle: Medicare physician payment
Advocacy News Roundup ... By Victoria Houghton, managing editor, July 1, 2021 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. For several years, physicians have endured a 2% Medicare payment reduction as part of sequestration — a component
Paradoxical biological reactions and Grandma Dora’s waterbed
By Warren R. Heymann, MD January 22, 2020 Vol. 2, No. 3 My late maternal grandmother Dora — a real ... balabusta (Yiddish for "mistress of the house") — was the first person I knew to get a waterbed. That raised eyebrows, until I explained that it comforted her octogenarian
CMS Targeted Probe and Educate (TPE) reviews are now in full swing
What is a Targeted Probe and Educate program? ... A Targeted Probe and Educate (TPE) program is a claim review process utilized by the Medicare Administrative Contractor (MACs) designed to help dermatologists reduce claim and billing denials as well as appeals through "one-on-one" corrective action assistance and is overseen by
Boards Fodder: Drugs and drug reactions
Select a title below to access the Boards Fodder PDF. ... NEW! UV radiation and sunscreen ... Access the PDF Advanced and immuno-therapies Adverse events from immune checkpoint inhibitors Biologics update 2019 Chemotherapy-specific cutaneous reactions Clinically relevant drug interactions in dermatology Drug interactions in dermatology, part 2 Disorders of hyperpigmentation
What's hot?
What's hot ... January 2, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Many dermatologists still check baseline labs prior to prescribing oral terbinafine or griseofulvin for adults and children with dermatophyte
Long COVID has a lot of nerve
By Warren R. Heymann, MD, FAAD Dec. 17, 2025 Vol. 7, No. 49 The profound medical and socioeconomic trauma of the COVID-19 pandemic may seem as though it is in the rearview mirror, but it is not. As of April 15, 2025, the CDC estimated that COVID-19 infections are growing
Reduce Drug Code Denials Related to Incomplete Claims Data
Claim denials for drug supplies are often the result of improper national drug codes (NDC) format or missing information related to the drug provided—vital information that is needed by the payer to appropriately adjudicate the claim. ... Physician claims for drugs supplied in the office must include the 11-character NDC
Fighting detrimental Medicare payment cuts
As our top federal legislative priority, your Academy fought all year against Medicare payment cuts of 8.5% or more that were scheduled to begin on Jan. 1, 2023. ... As a result, in late December, President Biden signed into law an omnibus spending package that included partial relief from the
Topical tacrolimus topics
By Warren R. Heymann, MD August 26, 2020 Vol. 2, No. 34 What were you doing in 2000? Worrying about counting chads in Florida? If you were a dermatologist, you were probably eagerly awaiting the release of topical tacrolimus (Protopic) and pimecrolimus (Elidel) two years later. These topical calcineurin inhibitors
Dermatology resident develops face masks from recycled medical supplies
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... DermWorld Weekly talks with Aditi Sharma, MD, a third-year resident in the department of dermatology at the University of California, Irvine, about how she produced a new type of protective face mask made from recycled
Clear cell papulosis: Clearly distinctive, clearly underrecognized
By Warren R. Heymann, MD June 3, 2020 Vol. 2, No. 22 One of my greatest joys in dermatology is diagnosing a disease that I have only read about, but then encounter in life. That "aha moment" is exhilarating! When attending patient presentations at dermatology conferences, I encourage my residents
Hidradenitis suppurativa and socioeconomic status: Food for thought (and benefit)
By Warren R. Heymann, MD ... Oct. 2, 2016 ... We see many patients with hidradenitis suppurativa (HS), especially in our Camden practice. I am certainly not surprised by the well-documented comorbidities of obesity and smoking (1), which may play a role in the pathogenesis of the disease. While
Dermatomyositis oddities: Could one be responsible for the other?
By Warren R. Heymann, MD Sept. 19, 2016 So much about dermatomyositis (DM) has intrigued me since medical school. Over the years, I have probably read more about this disease than any other malady. I am always amazed how I much more there is to learn. ... There were two
AADA advocacy win: CMS suspends CLIA lab director enforcement policy
As a direct result of advocacy by the AADA, CMS will not enforce provisions of its revised CLIA laboratory director policy that had excluded board-certified dermatologists from directing moderate- and high-complexity laboratories. ... Specifically, CMS will: ... Allow for individuals qualified as technical supervisors to qualify as high-complexity laboratory directors
The H syndrome – Understanding Y
By Warren R. Heymann, MD April 15, 2020 Vol. 2, No. 15 It has been more than a decade since the H syndrome was described by Molho-Pessach et al, in their report of 10 patients from 6 Arab consanguineous families. (1) More than 100 cases have now been reported worldwide.
Getting steamed over vaping
By Danielle DeHoratius, MD January 29, 2020 Vol. 2, No. 4 Danielle DeHoratius, MD ... To call vaping an epidemic is an understatement. As of Oct. 15, 2019, the CDC has confirmed 33 deaths among the 1,479 lung injuries associated with the use of e-cigarettes (1). Every state but Alaska
Monitoring infantile hemangiomas: What’s the score?
By Howard B. Pride, MD, FAAD Geisinger Medical Center, Department of Dermatology Aug. 11, 2021 Vol. 3, No. 32 Infantile hemangiomas (IH) are common vascular tumors that generally run a self-limited course of rapid growth in the first 2-3 months of life, slow growth for another 4-6 months, and then
Glucose monitors: Not as sweet as they seem
By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial
April 7, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 7, 2021 ... Applying 2021 E/M coding concepts in everyday practice – Part 2 DermWorld Insights and Inquiries : Keeping an eye on melanoma AAD collaborates with OM1 to enhance
Much ado about nothing in dermatopathology
By Warren R. Heymann, MD Dec. 9, 2020 Vol. 2, No. 48 In a utopian dermatology practice, an astute dermatologist will establish an exacting differential diagnosis, biopsy the most revealing lesion utilizing a technique providing an optimal sample, label the bottle correctly, fill out a requisition form with care and
Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid
By Warren R. Heymann, MD Oct. 7, 2020 Vol. 2, No. 40 It is not my imagination — I have been seeing more cases of bullous pemphigoid (BP) than ever. This is likely a function of an aging population in concert with an increase of drug-induced cases, notably with dipeptidyl
Are teens tanning less?
Go to AAD Home ... Go to AAD Home ... Menu ... Signs point to progress, but work remains ... Signs point to progress, but work remains ... By Ruth Carol, contributing writer It appears that fewer teens are indoor tanning in recent years, but the data are sparse. Regulations
Life insurance 101: Options and considerations
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 2, 2019 Life
Viva ex vivo dermoscopy?
By Warren R. Heymann, MD March 12, 2017 Evaluation of dermoscopic features on a formalin-fixed specimen (ex vivo dermoscopy) using a smartphone attached to a dermoscope. ... Credit: ... JAAD It has been said that the best "special stain" is a deeper section — wise words indeed. While always gratifying
Twenty years of imiquimod taking its toll on lentigo maligna — Where are we?
By Warren R. Heymann, MD February 12, 2020 Vol. 2, No. 6 Although Y2K never amounted to much, a solitary case report that year changed the dynamic in treating a vexing problem — melanoma in situ of the lentigo maligna (LM) subtype. Ahmed and Berth Jones reported treating an 88-year
Dermatologists will increasingly meet mammalian meat allergy
By Warren R. Heymann, MD March 20, 2019 Vol 1, No. 2 It has been a decade since Van Nunen et al detailed 25 patients living in a tick-endemic region of Sydney, Australia, who developed a red meat allergy following large, local reactions to tick bites. (1) Tick-induced mammalian meat
July 27, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 27, 2022 ... Facial hyperhidrosis: Botulinum toxin A injection vs. topical glycopyrrolate DermWorld Insights and Inquiries : JAKne is on the horizon Dupilumab for chronic prurigo, chronic idiopathic pruritus Safety
PDF of Retinoid biology part 2
boards’ fodder Review of Retinoid Biology: Part 2 Mariana Phillips, MD.
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive
Advocacy Update Mar. 18, 2025
IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key
2024 MIPS update
What dermatologists need to know about this year’s MIPS reporting. ... Feature ... By Allison Evans, Assistant Managing Editor, May 1, 2024 "If you provide Medicare services, MIPS is a must when it comes to your reimbursement," said Florida dermatologist Shawna Flanagan, MD, FAAD, member of the Academy’s Practice Management
New American Academy of Dermatology survey shows most Americans are not concerned about skin cancer, even if they are at risk
Board-certified dermatologists urge the public to practice safe sun ROSEMONT, Ill. (April 25, 2023) — As an African American female, Ilia Smith didn’t think she would get melanoma. However, after years of tanning and being outdoors, her life changed drastically when she was diagnosed with stage 2 melanoma. While Ilia
PDF of Histiocytosis
X) Letterer–Siwe Young infants Scalp, face trunk, but- • Visceral and bone More epidermotropism, (<2
Shining a light on the Sunshine Act
Legally Speaking ... Daniel F. Shay, Esq. is a health care attorney at Alice G. Gosfield and Associates, P.C. ... By Daniel F. Shay, Esq., July 2, 2018 The "Sunshine Act" as it has come to be known (stemming from Sen. Charles Grassley’s position that sunshine is the best disinfectant)
PDF of Nominating Committee Member Rep. Regional Map
the PE WEST REGION OF THE UNITED STATES QC ON AND CANADIAN PROVINCES ONLY NS (Shown in Pink) ND WA
Is your dermatology practice's website ADA compliant?
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, DC, and serves as legal counsel for the AAD and AADA. ... By Christina L. Krysinski, JD, and Robert M. Portman, JD, September 2, 2019 The Americans with Disabilities
Shedding light on tumoral melanosis
By Warren R. Heymann, MD, FAAD Oct. 9, 2024 Vol. 6, No. 41 Tumoral melanosis (TM) is a worrisome and confounding lesion for dermatologists and dermatopathologists alike. TM presents as darkly pigmented macules, papules, or nodules mimicking the appearance of a melanoma. Most cases are associated with either partial or
Dupilumab’s growing pains
By Warren R. Heymann, MD January 8, 2020 Vol. 2, No. 1 Dupilumab has been a valuable addition to dermatologists’ therapeutic palette in managing atopic dermatitis (AD). The biologic agent was released in 2017, indicated for moderate to severe AD, and is now approved for patients who are at least
Psoriatic disease and thyroid conditions
Research indicates that people with psoriasis and psoriatic arthritis have an increased risk of developing thyroid disease. ... Psoriatic disease and thyroid conditions ... Click to view and download the infographic. ... Download Source: ... www.jaad.org/article/S0190-9622(18)32985-2/pdf More information: ... Psoriasis Resource Center Help and Chat
Here comes summer (and sunscreen conversations)!
By Warren R. Heymann, MD April 29, 2020 Vol. 2, No. 17 As the summer solstice approaches, days will lengthen, as will patient-related conversations regarding sunscreen use. In this anxiety-ridden age, with all the information overload, patients’ questions have expanded beyond what sunscreen we recommend. Concerns for safety — both
Turning our attention to melanoma risk in Turner syndrome
By Warren R. Heymann, MD, FAAD July 2, 2025 Vol. 7, No. 26 "…at the endocrine clinic and in private practice, I had seen a few young girls who had not matured, and they were short in stature and they had short necks with a low hair line and increased
PDF of Board of Directors Regional Map
NL 9 BC 40 NL AB SK MB 9 47 4 12 PE QC 1 ON 64 NS 140 20 WA ND MT NB 333 46 22
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...
2025 AAD Innovation Academy Attendee Statistics
Innovation Academy Attendance over the years: 2024 – Seattle, WA ..................................
Deeper thoughts about acne keloidalis nuchae
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, February 1, 2026 Vol. 8, No. 2 Wallace Clark taught me the truism that thinking often ceases when a diagnosis is rendered. The clinical diagnosis of acne keloidalis nuchae (AKN) is straightforward. Embarrassingly, I had not given much thought
Shingles and heart health
Adults who have had shingles may be at a higher risk for heart problems. ... Shingles and heart health ... Click to view and download the infographic. ... Download Sources www.reuters.com/article/us-health-shingles-heart-stroke-idUSKBN19O27U www.onlinejacc.org/content/70/2/295?download=true More information Shingles: Overview, symptoms, causes, and treatment Help and Chat
This month’s news from across the specialty
What’s hot ... December 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD Our surgical prep may benefit non-surgical elderly patients. A study of extended bacterial decolonization in 28,956 nursing home
Striving for hard facts about water softening in atopic dermatitis
By Warren R. Heymann, MD, FAAD Aug. 18, 2021 Vol. 3, No. 33 With the success of dupilumab in managing atopic dermatitis (AD), and new agents on the horizon (IL-13 inhibitors lebrikizumab and tralokinumab; the IL-31 inhibitor nemolizumab; targeted anti IL-17, IL-22, and TSLP inhibitors; JAK inhibitors; and the PDE4
Digital media kit: DermWorld rate card
DermWorld print rates ... Download a PDF of the 2026 DermWorld print rate card. Download a PDF of the DermWorld print specifications . ... BW ... 1x ... 6x ... 12x ... 24x ... 36x ... Full page ... $3,185 ... $3,015 ... $2,760 ... $2,440 ... $2,350 ... Full
Recognizing toxic epidermal necrolysis-like acute cutaneous lupus erythematosus ASAP
By Warren R. Heymann, MD, FAAD November 10, 2021 Vol. 3, No. 45 ASAP, the well-recognized acronym for "as soon as possible," takes on special significance for dermatologists confirming the diagnosis of toxic epidermal necrolysis (TEN). In 2004, Ting et al introduced an alternative definition of the ASAP acronym —
The profound dermatological manifestations of COVID-19: Part IV – Cutaneous features
By Warren R. Heymann, MD April 22, 2020 Vol. 2, No. 16 Disclaimers: This commentary was written on April 17, 2020 for a publication date of April 22, 2020. The issues related to the COVID-19 pandemic are changing by the millisecond. The content included in this commentary may no longer
Melanoma controversies
Screening, biopsy practices questioned as incidence rate increases ... Feature ... By Jan Bowers, contributing writer, September 1, 2021 At first glance, dermatologists would seem to be wildly successful in their decades-long effort to detect and remove cutaneous melanoma lesions before they can metastasize and become deadly. According to the
Incysting on understanding pilar cysts
By Warren R. Heymann, MD July 15, 2020 Vol. 2, No. 28 Chances are you will see patients with at least one pilar cyst today. You will reassure them of their benignity, stating that the risk of their becoming cancerous is infinitesimal, and perhaps you will excise some lesions. Inquisitive
Recognizing mpox
The information on this page was created by the Academy’s Ad Hoc Task Force to Develop Mpox Content. Mpox (monkeypox) is caused by the mpox virus, which belongs to the ... Orthopoxvirus genus in the family Poxviridae. ... 1 ... Though mpox is rare, it is endemic in Central and West
2024 AAD Innovation Academy | Official exhibitor suppliers
Experient) is the official housing provider for the 2024 AAD Innovation Academy Meeting in Seattle, WA
The profound dermatological manifestations of COVID-19: Part III
By Warren R. Heymann, MD April 8, 2020 Vol. 2, No. 14 Disclaimers: This commentary was written on April 5, 2020 for a publication date of April 8, 2020. The issues related to the COVID-19 pandemic are changing by the millisecond. The content included in this commentary may no longer
Trialing it out
In Practice ... Craig Leonardi, MD, from Central Dermatology in St. Louis, specializes in treatment of moderate to severe psoriasis and other dermatologic diseases. He is also an adjunct professor of dermatology at St. Louis University Medical School. ... By Victoria Houghton, assistant managing editor, July 2, 2018 Dermatology World
What are the CLIA requirements for lab operations?
Thanks to persistent ... advocacy by the AADA , CMS has suspended enforcement of a controversial CLIA policy that would have excluded board-certified dermatologists from serving as lab directors for moderate- and high-complexity labs. Under this suspension, CMS: ... Allows individuals qualified as technical supervisors to qualify as laboratory directors
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
Eczema and eye disease
Eczema affects more than your skin. Adults with eczema are at a higher risk of developing ocular diseases. ... Eczema and eye disease ... Click to view and download the infographic. ... Download Sources www.healio.com/dermatology/dermatitis/news/online/%7B39cf915c-23d6-49ac-9f37-10f770c50f9e%7D/atopic-dermatitis-associated-with-ocular-disease-risk www.jaad.org/article/S0190-9622(17)30360-2/fulltext More information Eczema Resource Center Adults with eczema should watch for eye problems Help
PS-Joint Position Statement on Buffered Lidocaine
Eye protection 2. Face mask 3.
Taking the challenge: Social media, adolescents, and the skin
By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the
PDF of Boards Fodder for Surgical complications Part 2: Long-term complications of cutaneous surgery
Academy of Dermatology | Association directions in residency boards fodder Surgical complications, part 2:
March 20, 2023 AAD/A Board of Directors agenda
Request to Survey 2. Strategic Plan VII.
Advocacy Update Feb. 4 2025
IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC
PDF of claims specs for MIPS 317
MMeaneaniinnggffuull M Measueasurre Ae Arreea:a: P Prrevevenenttiiveve CaCarree 2022 COLLECTION TYPE
APACHE no more
By Warren R. Heymann, MD Dec. 4, 2017 ... A, Dark red, linear plaque on posterior area of right lower leg. B, Slightly raised, scaly, undulating lesion measuring 50 × 12 mm. ... Credit: ... JAAD This commentary is about being DC (Dermatologically Correct), not PC (Politically Correct as in
October 28, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 28, 2020 ... Drug may offer prolonged improvement in chronic spontaneous urticaria DermWorld Insights and Inquiries : Looking into the whites of the mouth Why will dermatology experience a 2%
How can I use DataDerm to report for MIPS?
Asked and Answered ... November 29, 2018 DataDerm™ can help you report for all three MIPS categories in 2018: ... Quality Promoting interoperability (PI) Improvement activities (IA) Here’s how to get started: ... 1. Step one: Sign up. ... Complete the sign-up portal at ... https://dataderm.aad.org/signup/Login.aspx by ... Dec. 7,
2022 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... Dec. 28 - 2022: Best of DermWorld Insights and Inquiries Dec. 21 - Holiday Greeting 2022 Dec. 14 - A Frank discussion about earlobe creases Dec. 7 - Xylazine ("Tranq"): The potential for loss of life and
The profound dermatological manifestations of COVID-19 Part VI: Going to the dogs
By Warren R. Heymann, MD July 29, 2020 Vol. 2, No. 30 Disclaimers: This commentary was written on July 12, 2020 for a publication date of July 29, 2020. The issues related to the COVID-19 pandemic are changing rapidly. The content included in this commentary may no longer be factual
Changes to the Placement of Modifiers Starting on July 1st
On July 1, 2019, the Centers for Medicare and Medicaid Services National Correct Coding Initiative (CMS/NCCI) Procedure-to-Procedure (PTP) Edits, Version 25.2 will go into effect. The MLN Matters Number: MM11227 (CR 11227) released on March 29 announced the release of the 2019 third quarter updates to the NCCI/PTP edits. ...
Short duration cyclosporine may undress DRESS
By Warren R. Heymann, MD July 22, 2016 DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) is a severe drug-induced hypersensitivity syndrome (DIHS) that may affect adults and children. The eruption of DRESS usually appears 3 weeks to 2 months after introduction of the drug. The rash is primarily morbilliform,
Playing the field: Introducing tirbanibulin for actinic keratosis therapy
By Warren R. Heymann, MD January 27, 2021 Vol. 3, No. 4 Field therapy is a cornerstone of actinic keratosis (AK) management. Two years ago, a ... New England Journal of Medicine article demonstrated that 5-fluorouracil (5-FU) was the best among inadequate therapies (compared to imiquimod, MAL-PDT, and ingenol mebutate).
What challenges and barriers exist when patch testing children?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 1, 2021 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with JiaDe (Jeff) Yu, MD, about
CareCredit
An AAD preferred provider since 2012, CareCredit is a health, wellness, and personal care credit card that helps patients fit dermatology care into their health care budget, with promotional financing options that allow them to pay over time. ... 1 ... CareCredit celebrates 35+ years of helping patients move forward
Men in the Twilight Zoon
By Warren R. Heymann, MD February 19, 2020 Vol. 2, No. 7 It is a dimension as vast as space and as timeless as infinity. It is the middle ground between light and shadow, between science and superstition, and it lies between the pit of man's fears and the summit
Treating metastatic melanoma: Understanding a brave new world
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, April 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jane Grant-Kels, MD, and Daniel
What is quality improvement
What is Quality Improvement? ... Quality Improvement (QI) consists of systematic and continuous actions that lead to measurable improvement in health care services and the health status of targeted patient groups ... 1 ... . The Institute of Medicine identifies six dimensions of health care quality that can be used
Collodion babies and endocrine disorders: Another concern
By Warren R. Heymann, MD June 23, 2017 Collodion baby. Tight, shiny film or dried collodion reminiscent of the skin of a sausage covers the entire surface of this 2-day-old neonate whose mother was treated with infliximab throughout her pregnancy. ... Credit: ... JAAD Collodion baby (CB) describes an infant
Boards Fodder: Procedural dermatology
Select a title below to access the Boards Fodder PDF. ... NEW! A guide to actinic keratosis treatments ... Access the PDF NEW! Mohs micrographic surgery ... Access the PDF Alopecia areata treatment Antiseptics and sterilization methods Approach to longitudinal melanonychia Atopic dermatitis treatment Biopsy techniques Chemical peels Cosmeceuticals CPT
Shocking news: Heat shock protein inhibition finally enters the realm of dermatologic therapy
By Warren R. Heymann, MD, FAAD Oct. 23, 2024 Vol. 6, No. 43 Heat shock proteins (HSP) were serendipitously discovered by the brilliant Professor Ferruccio Ritossa in 1962 while studying nucleic acid synthesis in chromosomal puffs of ... Drosophila salivary glands. De Maio states, "Ritossa noticed something unexpected when cells
All awards, grants, and scholarships by American Academy of Dermatology
The Academy bestows a number of prestigious awards to recognize the contributions of individuals to the specialty as well as offering various grants and scholarships to assist recipients in furthering their areas of study and broadening knowledge in the field of dermatology. ... Awards ... Name ... Application opens ...
Yeast rising: Predicting the efficacy of candida antigen immunotherapy for warts
By Warren R. Heymann, MD Oct. 2, 2017 ... Numerous flat warts (verrucae plana) seen on upper extremities of patient with epidermodysplasia verruciformis. ... Credit: ... JAAD Perhaps I’m paranoid, but I always think that warts are laughing at me, or at least at whatever I throw at them —
Covfefe and the art of the diagnostic deal
By Warren R. Heymann, MD June 2, 2017 Progressive nodular histiocytosis. A, Multiple papulonodular lesions over upper extremities and trunk. B, Leonine appearance for coalescing of lesions on face. ... Credit: ... JAAD I don’t know what’s more frightening — making diagnoses on autopilot or being genuinely stumped and having
An incisive approach to chronic paronychia: The square flap technique
By Warren R. Heymann, MD Aug. 2, 2016 I cannot begin to guess how many patients I have seen with chronic paronychia (CP) since I started my residency 36 years ago. I know precisely how many patients I have referred for surgical correction of CP — zero! The reason for
Mogamulizumab for CTCL: Targeted therapy and immunotherapy crossing paths
By Ellen Kim , MD August 12, 2020 Vol. 2, No. 32 Preserving the host-immune system for as long as possible has been one of the guiding principles for me in treating patients with mycosis fungoides/Sezary Syndrome (MF/SS) subtypes of CTCL. As a CTCL clinical trial researcher, it has been
2022: Best of DermWorld Insights and Inquiries
December 29, 2022 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2022 — starting with the most popular issue of the year. ... 1. Coming full circle (almost)
Spironolactone: An increasingly recognized hero in acne therapy
By David A. Wetter, MD July 1, 2020 Vol. 2, No. 26 In 1983, Bonnie Tyler released the catchy and powerful anthem, "Holding Out for a Hero." Emotion exudes from the lyrics: ... I need a hero I’m holding out for a hero ‘til the morning light He’s gotta be
Can topical ketoconazole tip the scales for acne vulgaris?
By Warren R. Heymann, MD Oct. 21, 2020 Vol. 2, No. 42 "Now trending." How often have you seen that phrase when you go online? When it comes to trends in treating acne vulgaris (AV), despite the new addition of oral sarecycline and the release of topical minocycline foam, there
Clinical information
1. How contagious is measles? ... Measles is a highly contagious virus, much more contagious than the common cold and even more contagious than other outbreaks like smallpox or Ebola. ... 1 ... Measles is potentially transmissible even after brief exposures and at distances up to 30 meters. ... 2
Pityriasis rubra pilaris: Check a TSH!
By Warren R. Heymann, MD ... June 10, 2016 ... There are myriad ways to mine the data from the review of 100 cases of PRP by Ross et al, however, one key finding will change the way I will assess these patients — 20% were hypothyroid! (1) ... There
Parabens — A common allergen with lots of hype and no real harm
By Christen M. Mowad, MD Sept. 4, 2019 Vol. 1, No. 26 Every year for the past 20 years, the American Contact Dermatitis Society (ACDS) has highlighted an allergen. Most often the particular allergen is selected because it is new and emerging, such as methylisothiazolinone in 2013. (1) Sometimes, it
March 31, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 31, 2021 ... Studies show skin rashes are highly predictive of positive COVID-19 results DermWorld Insights and Inquiries : Netherton syndrome — From apex to nether New AAD research grant
Necrotizing infundibular crystalline folliculitis: Not yet crystal clear
By Warren R. Heymann, MD, FAAD Jan. 29, 2025 Vol. 7, No. 4 Time and exposure to several articles are necessary to crystallize a novel clinicopathological correlation in my mind. Such is the case with necrotizing infundibular crystalline folliculitis (NICF). I suspect that I have seen this condition but have
Primary sclerosing cholangitis associated with pyostomatitis vegetans and pyodermatitis vegetans: A potentially bilious situation
By Warren R. Heymann, MD Aug. 29, 2016 Inflammatory bowel disease may be associated with multiple cutaneous manifestations including pyoderma gangrenosum (PG), erythema nodosum, or directly by fistulae or "metastatic" Crohn disease. Seven cases of pyostomatitis vegetans-pyodermatitis vegetans (PSV-PDV) were reviewed. All 7 patients had inflammatory bowel disease (IBD) —
Difficulty differentiating palmar psoriasis from eczema: Can dermatopathologists lend a Hand?
By Warren R. Heymann, MD July 2, 2017 Clinical manifestations of palmar skin lesions. A, Palmar psoriasis appeared as scattered hyperkeratotic scaly round patches over the entire palm. B, Hand eczema appeared as scaly patches on the palm and phalanges. C, Hyperkeratotic hand dermatitis appeared as sharply demarcated areas of
Taking psoriasis by the throat
By Warren R. Heymann, MD Nov. 2, 2016 Once the transient satisfaction of explaining the association of streptococcal infections with psoriasis (guttate, vulgaris, or pustulosis palmaris et plantaris) passes, the reality of treatment must be addressed. Of course we’ll prescribe the usual regimens — topical steroids, phototherapy, retinoids, biologics, etc.,
October
Issue ... October January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... This year, the ADA celebrates its 30th anniversary What's hot ... This month's news from across the specialty Clinical Applications ... What role can
June
Issue ... June January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor What's hot ... What's hot? Cracking the Code ... Components of evaluation and management 2 Acta Eruditorum ... New urticaria guidelines
A point to make about punctate, pigmented, and verrucous papillomatosis
By Warren R. Heymann, MD July 25, 2016 What is your mental image of the Gougerot-Carteaud (GC) syndrome? I equate it with confluent and reticulated papillomatosis, presenting on the trunk with hyperpigmented minimally raised plaques. The KOH examination is negative and there is a quick, characteristic response to antibiotics such
Bowel-associated dermatosis-arthritis syndrome (BADAS): The story behind the acronym
By Warren R. Heymann, MD, FAAD March 30, 2022 Vol. 4, No. 13 Justifiably, the COVID-19 pandemic has focused the world’s attention, however, another global pandemic threatens us — obesity. According to the World Health Organization, in 2016, more than 1.9 billion people are overweight (BMI > 25) and 650
Advisory Board news
Parliamentary procedures at a glance ... Review a PDF of parliamentary procedures . ... Upcoming Advisory Board meetings ... Advisory Board Reference Committee Hearing ... Colorado Convention Center, Rooms 601-603 ... Friday, March 27, 2026 ... 1:00-3:00 p.m. MT ... Advisory Board General Business Meeting ... Colorado Convention Center, Rooms
2026 AADA Legislative Conference
Save the date for the 2026 AADA Legislative Conference, held September 13-15 in Washington, D.C. ... Weren't able to attend the 2025 Legislative Conference? ... Catch up on the sessions in the AAD Learning Center. ... Get Started When ... Sept. 13-15, 2026 ... Where ... J.W. Marriott ... 1331
Pseudomolluscoid papules: A more accurate description than pseudoverrucous papules
By Warren R. Heymann, MD April 28, 2016 When patients ask me how I made their diagnosis so quickly, I politely tell them that if any particular lesion takes more than 25 milliseconds to diagnose, they really do have a problem. ... Today I saw a patient that made me
The profound dermatological manifestations of COVID-19: Part V – Pediatric multisystem inflammatory syndrome
By Warren R. Heymann, MD May 13, 2020 Vol. 2, No. 19 Disclaimers: This commentary was written on May 7, 2020 for a publication date of May 13, 2020. The issues related to the COVID-19 pandemic are changing by the millisecond. The content included in this commentary may no longer
Provider to Patient Exchange objective
Measure: Provide Patients Electronic Access to their Health Information (PI_PEA_1) ... DESCRIPTION For at least one unique patient seen by the MIPS EC: 1) the patient (or patient-authorized representative) is provided timely access to view online, download, and transmit his or her health information; and 2) the MIPS EC ensures
Provider to Patient Exchange objective
Measure: Provide Patients Electronic Access to their Health Information (PI_PEA_1) ... DESCRIPTION For at least one unique patient seen by the MIPS EC: 1) the patient (or patient-authorized representative) is provided timely access to view online, download, and transmit his or her health information; and 2) the MIPS EC ensures
Twenty-first century pellagra
By Warren R. Heymann, MD, FAAD Sept. 10, 2025 Vol. 7, No. 36 With obesity (defined as a body mass index > 30) affecting more than 40% of the adult population of the United States (1), it is difficult to fathom that nutritional deficiencies still exist. Kiani et al. expertly
Unmasking the complications of personal protective equipment
By Christen Mowad, MD August 5, 2020 Vol. 2, No. 31 Allergic contact dermatitis and irritant contact dermatitis have long been identified as potential adverse reactions to personal protective equipment (PPE) most commonly due to gloves. The global pandemic caused by COVID-19 has heightened the need to use PPE as
Methotrexate toxicity: What’s in a name?
By Warren R. Heymann, MD Aug. 24, 2017 Methotrexate-induced skin toxicity: photographs of 4 illustrative cases. A, Erosions in psoriatic plaques over the torso (patient 1). B and C, Ulcerated and reticulated psoriatic plaques over the arms (patient 2). D, Small shallow cutaneous erosions (patient 4). E, Mucosal erosions over
When to see red in linear erythronychia — Malignant onychopapilloma
By Warren R. Heymann, MD, FAAD June 29, 2022 Vol. 4, No. 26 With every passing year, I take increasing comfort in the stability of the linear erythronychia of my left fifth digit. The presumed diagnosis of an onychopapilloma (OP) is very reassuring because every article I ever read about
Beyond disfigurement: The potential for keratinocyte carcinoma in discoid lupus erythematosus
By Warren R. Heymann, MD, FAAD Jan. 10, 2024 Vol. 6, No. 2 Cosmetic disfigurement due to scars and dyspigmentation is the main complication of discoid lupus erythematosus (DLE). The current classification of cutaneous lupus erythematosus (CLE) includes acute cutaneous LE (ACLE), subacute LE (SCLE), chronic cutaneous LE (DLE, LE
Reflections on infantile perianal pyramidal protrusion and Hippocrates
By Warren R. Heymann, MD, FAAD May 29, 2024 Vol. 6, No. 22 Patient safety and quality improvement have been at the forefront of medical care since the publication of "To Err is Human: Building a Safer Health System" by the Institute of Medicine, which estimated that as many as
Bank of America - Practice Solutions
When you need financing for your dermatology practice, you want to work with someone who understands your industry. For over 25 years, Bank of America Practice Solutions has helped dermatologists across the nation reach their goals through smart financial solutions ... 1 ... and expert guidance. Whether you own a
DWI&I Holiday Greeting 2023
By Warren R. Heymann, MD, FAAD Dec. 20, 2023 Vol. 5, No. 50 Dear ... DWI&I Devotee: ... I always look forward to writing my annual holiday greeting, but admittedly, doing so this year has been a source of angst and consternation. The past few years have been about the
Health Information Exchange
Important note: Do not report on all three options ... For this objective, you may choose to report data for: ... The two existing HIE measures, ... or The HIE Bi-Directional Exchange measure, ... or The Enabling Exchange Under TEFCA measure. ... Measure: Support Electronic Referral Loops by Sending Health
Is there a best approach to widespread actinic keratoses?
By Deirdre Connolly, MD and Naomi Lawrence, MD April 10, 2019 Vol. 1, No. 5 Journal of the American Academy of Dermatology Volume 72, Issue 2, Pages e57-e59 (February 2015) ... Widespread actinic keratoses (AKs) are problematic to both patients and physicians, not only because of their pre-cancerous nature, but
AADA Advocacy Win: CMS suspends CLIA lab director enforcement policy
June 23, 2025 Advocacy News Alert As a direct result of advocacy by the AADA, CMS will exercise enforcement discretion on several provisions of its revised CLIA laboratory director policy that had excluded board-certified dermatologists from directing moderate- and high-complexity laboratories. Specifically, CMS will: ... Allow for individuals qualified as
Dermatology practice staff by the numbers
Facts at your Fingertips ... By Emily Margosian, July 2, 2018 Nurses, aestheticians, billers — who’s most likely to be spotted working in the average dermatology practice? Aside from dermatologists, medical assistants and practice administrators are the most widely employed across all practice settings, according the 2017 AAD Practice Profile
Becoming whipped up over flagellate dermatoses
By Warren R. Heymann, MD ... July 13, 2017 ... A, A 44-year-old male patient with characteristic flagellate dermatitis after ingestion of shiitake. B, Same patient 4 days after balneo PUVA therapy. ... Credit: ... JAAD The literature on flagellate dermatoses has been whipped into frenzy. The initial description
Reopening the dermatologic surgery office in the COVID-19 era
By Ashley Decker, MD, Henry Heaton, MD, and Naomi Lawrence, MD May 20, 2020 Vol. 2, No. 20 Authors Ashley Decker, MD, Naomi Lawrence, MD, and Henry Heaton, MD, wearing PPE. ... The coronavirus disease 2019 (COVID-19) presents extraordinary challenges to the health care community, including dermatology and dermatologic surgery.
Cutting giant congenital nevi down to size molecularly
By Warren R. Heymann, MD Oct. 2, 2019 Vol. 1, No. 30 Personally, I find giant congenital melanocytic nevi (GCMN) to be among the most unnerving skin lesions imaginable. The risk of melanoma, leptomeningeal melanocytosis, and psychosocial stresses are profoundly burdensome to patients, their families, and health care professionals. With
How can I get a receipt for payments made to the Academy?
Asked and Answered ... March 1, 2020 For all Academy-related payments — membership dues, past orders, a subscription to ... Dialogues in Dermatology — AAD members can access their receipts as follows: ... 1. Visit ... www.aad.org/members 2. Sign in to your member profile ... 3. Click the "Account" tab
Dermatology World Directions in Residency
DermWorld Directions in Residency is published quarterly by the Academy. The publication includes features that will help you make the most of your residency experience and prepare you for the next stages of your career. ... Download latest issue in PDF Residents: Do you have good content for ... DermWorld
Increasing evidence for the use of topical timolol for pyogenic granulomas
By Warren R. Heymann, MD May 16, 2016 There are multiple approaches to treating pyogenic granulomas (PGs). If possible, I usually perform a shave biopsy and electrodesiccate the base of the lesion. Certainly there are times when that approach may not be optimal, such as a PG the face of
August 20, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 20, 2025 ... Oral vs. topical finasteride: Sexual, neuropsychiatric AEs DermWorld Insights and Inquiries : Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma Are topical
Health Information Exchange
Important note: Do not report on all three options ... For this objective, you may choose to report data for: ... The two existing HIE measures, ... or The HIE Bi-Directional Exchange measure, ... or The Enabling Exchange Under TEFCA measure. ... Measure: Support Electronic Referral Loops by Sending Health
Academic Dermatology Leadership Program (mentee)
The Academic Dermatology Leadership Program (ADLP) is a comprehensive program that requires a full-year commitment. ... Applications for the 2027 Academic Dermatology Leadership Program will open July 2026 ... Please send me an email reminder when the application opens . ... By applying for this program, you are agreeing to
Congress must act to protect patients’ health care access
Statement from Terrence A. Cronin Jr., MD, FAAD, President of the American Academy of Dermatology Association WASHINGTON (Nov. 2, 2023) — CMS finalized cuts to the physician fee schedule for 2024, which will impact the ability of medical practices to cover expenses like equipment, rent, and nursing and office staff
Cellular neurothekeoma: A tribute to Barnhill and Mihm and a remembrance of Martin C. Mihm Jr., MD
By Warren R. Heymann, MD, FAAD Aug. 2, 2023 Vol. 5, No. 31 The profound sense of loss prompting people to endure waiting over 24 hours in a queue to pay their final respect to Queen Elizabeth II at Westminster Hall was an astonishing sight last year. The overwhelming majority
Speculating on spicules: Our incomplete knowledge of trichodysplasia spinulosa
By Warren R. Heymann, MD, FAAD December 15, 2021 Vol. 3, No. 49 For inexplicable reasons, there are certain differential diagnoses that I find particularly satisfying, one being disorders responsible for facial follicular spicules: follicular mucinosis (1), pityriasis folliculorum ... (Demodex folliculorum) (2), follicular hyperkeratotic spicules (myeloma immunoglobulin or cryoglobulin)
The pregnant pause in cutaneous lymphoma
By Jennifer Villasenor-Park, MD, FAAD Oct. 2, 2024 Vol. 6, No. 40 I first met Anne when she was 30 years old and was experiencing a significant flare of her mycosis fungoides. She had already lived with the disease for 18 years having been diagnosed at the age of 12
Juvenile lichen sclerosus: A loss of innocence
By Warren R. Heymann, MD August 19, 2020 Vol. 2, No. 33 Juvenile lichen sclerosus (LS) is a difficult disorder — symptomatically, emotionally, diagnostically, and therapeutically. During my residency it was "common knowledge" that juvenile LS would abate by adolescence. I am always curious how such perceptions become dogma, only
When ads subtract
By Warren R. Heymann, MD Aug. 2, 2018 "Could the skin lesion you’re seeing…actually be a deadly blood cancer?….Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and deadly hematologic cancer with skin lesions that may be mistaken for other skin disorders…When biopsying skin lesions, ask your pathologist to test
Thoughts about genital melanosis on Melanoma Monday
By Warren R. Heymann, MD May 1, 2017 Vulvar genital melanosis. The lesions on the posterior fourchette are dark brown to black in color while other superior macules in the labia minora and vagina are lighter brown. Additively, the lesions are more than 2 cm in diameter. The lesions are
PDF of urticaria guidelines for comment
1 Strong consensus ↑↑ We recommend that … Expert consensus 1 ≥90% agreement 13 Box 2.
Truth in advertising pathways
As AAD members identify examples of advertisements in their community that could mislead patients to believe they are receiving care from a dermatologist, the AAD has developed template letters for its members to contact the licensing board that regulates such individual. ... Scenario #1: A non-dermatologist physician holds oneself out
2026 AAD Annual Meeting: Donor Lounge
The AAD Donor Lounge is located in Room 107/109 in the Colorado Convention Center. The lounge will be open Friday, March 27 through Monday, March 30 during the hours listed below. Stop by and take advantage of a place to relax during the meeting, enjoy coffee or a bite, and
AAD | Prior Authorization Resources
The following resources are to assist physicians, medical staff, and patients effectively navigate through prior authorizations. ... Prior authorization podcast ... Download ... Practice Management Series: Prior Authorization: What a Pain! a podcast with John Barbieri, MD, MBA, FAAD, interviewed by Khang Nguyen, MD, FAAD. ... Prior authorization guidelines for staff
Lichenoid and granulomatous dermatitis: Points to ponder
By Kiran Motaparthi, MD June 10, 2020 Vol. 2, No. 23 Clinical-pathologic correlation is the foundation of dermatologic diagnosis; often this is straightforward, but on occasion, getting to the precise diagnosis requires great thought and sleuthing. If you receive a report from your dermatopathologist with a descriptive diagnosis of "lichenoid
Develop a nose for suspecting angiosarcoma
Angiosarcoma histopathology. Anastomosing dilated vessels, lined by crowded endothelial cells, extend between pre-existing collagen bundles. (Hematoxylin-eosin-saffron stain; original magnification: ×40.) ... Credit: ... JAAD By Warren R. Heymann, MD Nov. 12, 2018 Occasionally I read an article that disturbs me, because I know that I would miss the diagnosis, with
Directions in Residency archive
Download PDF versions of each issue ... Spring (PDF) ... Feature: Financial planning in residency: Frequently asked questions — Part 2 by David B. Mandell, JD, MBA ... Race for the Case: Spring 2026 by Marita Yaghi, MD, Uros Rakita, MD, and Stanley Skopit, DO, MSE, FAOCD, FAAD ... Boards
PRIDE without prejudice
By Warren R. Heymann, MD, FAAD July 30, 2025 Vol. 7, No. 30 As the years march on, I am bemused by having witnessed once-novel findings become mainstream affairs. I recall my excitement describing the development of paronychia in a 76-year-old woman with metastatic colon carcinoma who was participating in
Digging deeper into lupus erythematosus panniculitis
By Warren Heymann, MD May 5, 2021 Vol. 3, No. 18 Lupus erythematosus panniculitis (aka lupus erythematosus profundus, LEP) has a storied history. The famed clinician Harry Arnold noted that Kaposi (when he was Kohn) observed nodules in patients with lupus. (1) Debates and controversies ensued for decades, with many
How do I apply for a CLIA certificate?
There are two options available to physicians when applying for a CLIA certificate: ... Option 1 ... Go through your state CLIA office and submit appropriate application materials and fees. ... CMS offers contact information for each state . ... Option 2 ... Go through an accreditation agency that certifies
MIPS 2022 program highlights
Eligible clinicians ... Revised the definition of a MIPS eligible clinician to include: ... Clinical social workers ... Certified nurse mid-wives ... Eligibility criteria ... The low volume threshold remains the same as 2021 and includes three aspects of covered professional services: ... Allowed charges ... Number of Medicare patients
Phacing the future: When patients with PHACE syndrome grow up
By Warren R. Heymann, MD June 24, 2020 Vol. 2, No. 25 The acronym PHACE syndrome, emphasizing the characteristic findings of this neurocutaneous syndrome: ... p osterior fossa malformations, ... h emangiomas, ... a rterial anomalies, ... c oarctation of the aorta and cardiac defects, and ... e ye abnormalities,
Topical minocycline for acne: A good Idea?
By Warren R. Heymann, MD May 28, 2016 Concerns about the safety of minocycline have been increasing over the past two decades, with rare, serious adverse immunologic reactions including DRESS syndrome, pneumonitis, nephritis, autoimmune hepatitis, and a lupus-like syndrome (1). There have been several reports of ANCA-positive polyarteritis nodosa (PAN)
Ultraviolet light, adipose tissue, and fantasies of summer
... By Warren R. Heymann, MD April 2, 2018 As I am preparing this commentary, the second Nor’easter within a week is in its frenzy. (Since that time there have been two more and it’s snowing today!) My longing for summer, enjoying the warm breezes enveloping our shore home
The profound dermatological manifestations of COVID-19
By Warren R. Heymann, MD March 18, 2020 Vol. 2, No. 11 Disclaimers: This commentary was written on March 12, 2020 for a publication date of March 18, 2020. The issues related to the COVID-19 pandemic are changing at breakneck speed. The content included in this commentary may no longer
AAD | Tool Drugs and Diseases
See a list of available drugs and dermatologic conditions available in the tool. ... Drug name ... 4% minocycline foam (Amzeeq®) ... Class 1 steroid ... Infliximab (Remicade®) ... Spesolimab (Spevigo®) ... 5-fluorouracil (Efudex®) ... Class 2 steroid ... Isotretinoin ... Sulfacetamide sodium-sulfur ... Abrocitinib (Cibinqo®) ... Clobetasaol ... Isotretinoin
Skin Cancer Awareness Month campaign reaches billions!
May is Skin Cancer Awareness Month, and in 2024 the Academy once again undertook a robust effort to spread awareness to the general public. Similar content did very well in 2022, did even better in 2023, and shows no signs of stopping in 2024! ... During the month, the Academy
Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: The aftermath
By Warren Heymann, MD May 26, 2021 Vol. 3, No. 21 The American Academy of Dermatology’s SkinSerious ... ® ... campaign highlights how dermatologists treat serious diseases. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) top the list. (1) Justifiably, all attention focuses on the immediate issues in an attempt
New American Academy of Dermatology survey reveals most Americans say sun protection is more important now than five years ago, yet many misunderstand how to protect themselves
Dermatologists urge the public to protect themselves from the sun to reduce skin cancer risk ahead of Melanoma Monday (May 2) and Skin Cancer Awareness Month ROSEMONT, Ill. (April 26, 2022) — In a recent survey of more than 1,000 U.S. adults, the American Academy of Dermatology found that while
Generalized multinucleate cell angiohistiocytomas and thoughts on diagnostic first impressions
By Warren R. Heymann, MD April 1, 2017 I became aware of multinucleate cell angiohistiocytomas (MCA) when I learned of an article published by friends who reported the first cases in the United States (1). The following abstract by Smolle et al (2) accurately described the entity, and my concept
AAD | Best Practices for Prior Authorization
Top strategies for prior authorization ... 1. The process of prior authorizations can be painful. Accept that it will take time. ... 2. Assign a dedicated staff member (such as a medical assistant) to handle prior authorization requests, so as a dermatologist, you have more time with patients and more
Senile gluteal dermatosis: The term “senile” is getting old and should be retired
By Warren R. Heymann, MD, FAAD Jan. 24, 2024 Vol. 6, No. 4 As my patients and I get older, inevitably I think more about geriatric dermatology. (1) There is a disorder I have seen on the gluteal region in mostly thin, older, sedentary patients — my recommendations of off-loading
Basic Dermatology Curriculum
The American Academy of Dermatology has a long history of involvement in medical student education. This curriculum was created by a work group of experienced dermatology educators and is based on the best available evidence. ... Note ... If this is the first time you are accessing the Academy's online
March 25, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 25, 2020 ... C MS extends 2019 MIPS reporting deadline DW Insights and Inquiries : The profound dermatological manifestations of COVID-19 – Part 2 Young Physician Focus : A legitimate
A niche within NICH
By Warren R. Heymann, MD February 26, 2020 Vol. 2, No. 8 Just when I thought I grasped the concept of congenital hemangiomas, new data raises novel questions. ... Compared to infantile hemangiomas that grow rapidly after birth and then involute, congenital hemangiomas arise and proliferate in utero. Although two
December
Issue ... December January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor Asked and Answered ... How can I use DataDerm to report for MIPS? What's hot ... What's hot? Cracking the Code
June 30, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 30, 2021 ... Treating atopic dermatitis with cognitive behavioral therapy: Does it work? DermWorld Insights and Inquiries : Deep learning in dermatopathology Sublingual tofacitinib for alopecia areata Biologic psoriasis treatments
The 21st Century Cures Act: What a difference a day makes
By Warren R. Heymann, MD, FAAD Sept. 24, 2025 Vol. 7, No. 38 The 21st Century Cures Act (Cures Act, CA) was signed into law on Dec. 13, 2016. (1) In April 2021, the Information Blocking Rule (IBR) of the CA went into effect, giving patients immediate access to notes,
January
Issue ... January January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor What's hot ... What's hot? Cracking the Code ... CPT 2018: What's new, part 2 Acta Eruditorum ... Can chimeric antigen
Prurigo pigmentosa as the “keto rash”: I’m a believer
By Warren R. Heymann, MD February 5, 2020 Vol. 2, No. 5 Patients are attuned to their diets — healthy, unhealthy, or trendy. Unquestionably, certain foods exacerbate specific dermatoses — just ask any dermatitis herpetiformis patient how they fare with a slice of Sicilian pizza. More often the situation is
Best of DermWorld Insights and Inquiries
Dec. 27, 2023 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2023 — starting with the most popular issue of the year. ... 1. After 23 years, a
Taking biologics to heart
By Warren R. Heymann, MD Oct. 16, 2016 Comorbidities related to psoriasis have dominated the dermatologic literature for more than a decade since Joel Gelfand published his seminal paper (1). In my 2008 commentary for ... Dialogues in Dermatology , I stated that "It remains to be determined if treating
November
Issue ... November January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... So, what's a Kodachrome? What's hot ... This month's news from across the specialty Clinical Applications ... When is pyoderma gangrenosum not pyoderma gangrenosum?
We’re in hot water! Vibrio vulnificus infections are heading north
By Warren R. Heymann, MD Dec. 16, 2020 Vol. 2, No. 49 When driving to work, I usually listen to our local 24-hour news station, paying half-attention as I’m mentally sorting out the upcoming day’s agenda. Upon hearing a report of several cases ... Vibrio vulnificus (Vv) at my hospital
The 2020 vision for nemolizumab in atopic dermatitis
By Warren R. Heymann, MD March 11, 2020 Vol. 2, No. 10 Over the past decade, I have noticed an inversion of the ratio of patients with severe psoriasis versus atopic dermatitis (AD) in my practice. The biologic revolution has clearly favored those afflicted with psoriasis; although dupilumab has improved
Topical amelioration of neuropathic pain and pruritus leading to painful consequences
By Warren R. Heymann, MD Dec. 26, 2016 Increasingly, compounded amitriptyline and ketamine have been utilized for the management of neuropathic pain and pruritus. A review of PubMed reveals its utility in erythomelalgia and diverse neuropathic disorders (peripheral neuropathy, radiation-induced neuropathy, chemotherapy-induced neuropathy, post-herpetic neuralgia, proctodynia, and pain associated with
Acquisition and loss: A tribute to Jouni Uitto, MD, PhD
By Warren R. Heymann, MD, FAAD Jan. 11, 2023 Vol. 5, No. 2 I was stunned and frozen in time and thought when Dr. Sylvia Hsu informed me that Dr. Jouni Uitto had passed away — a similar reaction as I experienced when hearing of President Kennedy’s or John Lennon’s
Skin in the news
Facts at your Fingertips ... By Emily Margosian, content specialist, April 2, 2018 In 2017, the Academy generated more than 8.8 billion media impressions in print and online — akin to reaching each person in the United States more than 26 times. Nevertheless, the year’s overall total marked a slight
Top drivers of dermatologist happiness
Facts at your Fingertips ... By Emily Margosian, assistant editor, September 2, 2019 What do a solo practitioner and employee at a large health system have in common? The same things make them pretty happy. According to data from the AAD’s 2019 Life in Practice Study, dermatologists across all practice
Can topical ketoconazole tip the scales for acne vulgaris?
By Warren R. Heymann, MD Oct. 28, 2020 Vol. 2, No. 43 How often do you perform an oral examination? If you’re like me, probably only under two circumstances — when the patient has specific complaints (soreness, a raised lesion, or a discoloration noted by their dentist), or when we
Skin cancer incidence and related deaths projected to rise in 2024
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, April 1, 2024 The latest data from the American Cancer Society (ACS) are in — offering new insights into the impact of skin cancer on public health in the United States. Each year, the ACS estimates the number of new
Our public-facing AAD.org content performs strongly
One of the many benefits of the Your Dermatologist Knows consumer positioning strategy is driving traffic to the public-facing pages of the AAD.org website. During the first five months of 2023, over ... 20 million visitors viewed webpages over ... 28 million times. In the same timeframe, the Academy updated
Volunteer duty, chapter 2
From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, June 1, 2021 Volunteer, n...person who performs/gives his/her services of own free will; v...to give/offer to give on one’s own initiative. I highlighted the main AAD volunteering opportunities in
2021: Best of DermWorld Insights and Inquiries
December 30, 2021 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2021 — starting with the most popular issue of the year. ... 1. Biotin supplementation for hair
New Medicare cards
In Practice ... Rachna Chaudhari is the AAD's practice management manager. Her column offers tips in response to common member questions. ... By Rachna Chaudhari, MPH, director of practice management, April 2, 2018 ... The Centers for Medicare and Medicaid Services (CMS) recently announced that it would be changing your
2026 Board Prep Plus Raffle
Official Rules & Regulations ... How to enter the Board Prep Plus "Board Bonanza" Raffle ... Residents can earn a raffle ticket by: ... Doing a test-drive of Board Prep Plus at the AAD Resource Center. ... Leaving a review of Board Prep Plus March 26 – March 29 (current
Dermatologists should not be in the dark about kratom
By Warren R. Heymann, MD, FAAD Oct. 11, 2023 Vol. 5, No. 41 Dermatological sleuthing mandates an ever-expanding knowledge database. The correct diagnosis may prove elusive if you do not know the right questions to ask. Astute clinicians have a differential diagnosis of cutaneous and/or mucosal hyperpigmentation, including heavy metal
How can I get involved with this year’s Legislative Conference?
Asked and Answered ... July 1, 2024 The 2024 AADA Legislative Conference will take place Sept. 8-10, at the JW Marriot in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the
Skin cancer incidence and related deaths projected to increase in 2025
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, May 1, 2025 The latest data from the American Cancer Society (ACS) are in — offering new insights into the impact of skin cancer on public health in the United States. Each year, the ACS estimates the number of new
Streamlining the claim denial process in your practice
Claim denials are a reality for every dermatology practice. It is wise to be proactive and understand what you need to do when you receive a claim denial. Streamlining your claim denial process requires understanding the meaning behind each denial on the explanation of benefits (EOB) and the appropriate action
How can I get involved with this year’s Legislative Conference?
Asked and Answered ... July 1, 2023 The 2023 AADA Legislative Conference will take place Sept. 10-12, at the Conrad Hotel, in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the
Should systemic steroids be avoided in atopic dermatitis?
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, July 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jonathan I. Silverberg, MD, PhD,
Slammed by slime
By Warren R. Heymann, MD Sept. 16, 2020 Vol. 2, No. 37 Visiting Nickelodeon Studios in Orlando, Florida in the early 1990s was a religious experience for my family. Watching a live recording of ... Double Dare, my daughters were fervently praying to be among the chosen few to be
Skin cancer snapshot: National rates fall, men remain vulnerable
Facts at your fingertips ... By Emily Margosian, assistant editor, May 1, 2020 The results of the American Cancer Society’s (ACS) 2020 projections are in. Each year, the ACS estimates the number of new cancer cases and deaths in the United States by compiling the most recent data on population-based
Patient preference in dermatologist attire: A lesson from “Annie”
By Warren R. Heymann, MD June 5, 2016 The physician-patient relationship is predicated on trust and confidence. Impressions form rapidly and physician attire is an important component on how patients perceive their physician(s). ... Fox et al surveyed 255 patients (with 63% from a medical dermatology clinic, 24% a dermatologic
PDF of Diagnosis and associations
Radial ray anomalies, poor growth, genitourinary problems, acute C, D1, D2, myelogenous leukemia, and 90
Vasculitis on the run
By Warren R. Heymann, MD, FAAD July 10, 2024 Vol. 6, No. 28 I am not a runner, but I live vicariously through my residents who are. This weekend, our first-year resident, Erika Tvedten, will run the Philadelphia marathon for the first time. I have been intrigued (and impressed!) by
Mentorship mentation: Bringing out the best of us!
By David A. Wetter, MD Sept. 9, 2020 Vol. 2, No. 36 I have been experiencing sports withdrawal during this COVID-19 life pause. I even (excitedly) gobbled up the recently televised NBA HORSE competition. Currently my family and I are enjoying ESPN’s 10-hour documentary ... The Last Dance , which
2025 AAD Annual Meeting Fees, Session Access, and Eligibility PDF
REGISTRATION CATEGORY Additional information can be found at aad.org/AM25 Physician members $1,030 $1,235 YES $90
Dermatology and dermatopathology awake: now is the time to embrace the artificial intelligence revolution
By Jason B. Lee, MD June 23, 2021 Vol. 3, No. 25 In 1991, the late Dr. A. Bernard Ackerman sounded the alarm about the decline in the interest in dermatopathology by dermatologists in an effort to preserve this foundational subspecialty within dermatology. (1) Although not with the same urgency,
Another mastocytosis surprise: IgM on DIF in bullous mastocytosis
By Warren R. Heymann, MD ... May 2, 2016 ... If I read my horoscope this week, it would no doubt say "Beware of any preconceived notions in your patients with mastocytosis." ... Now that I have expanded my horizons about TMEP, I also need to reconsider the notion that
Changing a long-standing habit
By Warren R. Heymann, MD April 16, 2016 Topical corticosteroid has no influence has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratosis (AK): A randomized clinical trial. ... This is a randomized controlled clinical trial of patients with multiple AK and
AAD letter to the Wall Street Journal in response to “$500,000 Pay, Predictable Hours: How Dermatology Became the ‘It’ Job in Medicine”
American Academy of Dermatology President Seemal R. Desai, MD, FAAD Letter to the editor originally submitted to the Wall Street Journal ... on Nov. 20, 2024 ROSEMONT, Ill. (Dec. 2, 2024) — On behalf of the American Academy of Dermatology and its 21,000 members, I am writing to express very serious concerns
American Academy of Dermatology warns that homemade sunscreens are not proven to be effective and may leave users vulnerable to skin cancer
American Academy of Dermatology Secretary-Treasurer Daniel D. Bennett, MD, FAAD ROSEMONT, Ill. (July 2, 2024) — While the American Academy of Dermatology is aware of reports of people using homemade sunscreens, research shows that most homemade sunscreens lack effective sun protection, leaving users vulnerable to sunburn, premature skin aging and
JAAD ranks no. 1 among dermatology journals
The Journal of the American Academy of Dermatology’s impact factor remains #1 in field ROSEMONT, Ill. (July 2, 2024) — The ... Journal of the American Academy of Dermatology remains the top peer-reviewed journal in its field, according to the 2023 journal impact factor rankings recently published by Clarivate’s Journal
Anterolateral leg alopecia: An example of a new dermatologic statistic — seen but unrecognized
By Warren R. Heymann, MD March 4, 2020 Vol. 2, No. 9 Aside from my family, my two greatest passions in life are dermatology and baseball. There is an infinite amount to learn in each discipline — for wisdom in each I turn to Bill James (two different people). Most
PDF of industry expert sessions for theater 2
INDUSTRY EXPERT SESSIONS Friday, March 20, 2020 Theater 2 These unique sessions provide
Frontal fibrosing alopecia: Bewitched, bothered, and bewildered
By Warren R. Heymann, MD Feb. 13, 2017 Women given the diagnosis of frontal fibrosing alopecia (FFA) with different severity grades. A, FFA grade I/V in a premenopausal 30-year-old woman, with a less than 1-cm wide area of cicatricial skin produced by the recession of the frontal and temporal hairline.
Providing consistent quality care requires due diligence.
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, July 2, 2018 Sometimes the news makes me cringe, especially reports about a physician or their non-physician providers making questionable treatment decisions. Even though the stories are usually about
Knuckling down on knuckle pads
By Warren R. Heymann, MD April 1, 2020 Vol. 2, No. 13 Today is April Fools’ Day. Thus far, 2020 has felt like April Fools’ Year. All of us are dealing with COVID-19, 24/7. During World War II, morale was lifted by the song "There’ll be bluebirds over the White
Obituaries
Obituaries ... By Jerry Graff, MD, September 2, 2019 The Academy recently learned with sorrow of the passing of the following members of the dermatologic community. ... JOHN L. AELING, MD, of Orlando, Florida, Oct. 26, 2018, at age 82. Trained at National Capital Area Consortium Dermatology Residency Program. ...
PDF of Vascular malformations
No treatment necessary as many fade in 1-2 years.
PDF of MIPS readiness checklist
to prepare your for MIPS reporting. 2019 MIPS Readiness Checklist 1 Determine if you are eligible 2
PDF of measure AAD 2 flowchart
DIRECT EHR AAD #2: Psoriasis: Screening for Psoriatic Arthritis — National Quality Strategy Domain:
Keeping up is hard to do: The need for true grit
By Warren R. Heymann, MD Oct. 5, 2017 One of the daunting challenges in practicing dermatology (or any branch of medicine) is keeping abreast of advances in the literature to optimize patient care. As a clinician-educator, I have always had an interest in how we learn best. For full disclosure,
Preferentially expressed antigen in melanoma (PRAME)
By Jason B. Lee, MD, FAAD May 10, 2023 Vol. 5, No. 19 In 1980, the discovery of S100 protein expression in cultured metastatic melanoma cell lines (1) stirred excitement in the pathology community for its potential role as a diagnostic marker for melanoma. The excitement was short-lived once it
Focus on modifier 25
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, September 2, 2019 Test your knowledge: Focus on modifier 25 ... Take the quiz to see if you're up
Coding and documentation for hyperhidrosis
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, November 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Clear and concise documentation is essential
DWI&I Holiday Greeting 2020
By Warren R. Heymann, MD Dec. 23, 2020 Vol. 2, No. 50 Dear ... DWI&I Devotee: ... For my 65th birthday this year, my wonderful older brother George presented me with a marvelous gift — a leather-bound compilation of the front page of ... The New York Times including every
How to maintain your EHR
Dealing with your EHR can be cumbersome, but follow these tips to optimize your EHR and make your use more efficient. ... 1. Connect leadership and EHR users ... Boosts provider satisfaction long-term and reduces slowdown. ... 2. Enhance hardware and built-environment solutions ... Implement side-by-side seating for physicians, clinical
The profound dermatological manifestations of COVID-19: Part VII — Who was that masked man?
By Warren R. Heymann, MD Sept. 23, 2020 Vol. 2, No. 38 Disclaimers: This commentary was written on Sept. 12, 2020 for a publication date of Sept. 23, 2020. The issues related to the COVID-19 pandemic are changing rapidly. The content included in this commentary may no longer be factual
PDF of MIPS 2022 Large and Small Snapshots
consecutive days; last day to begin is Oct 3, Total minimum 90 consecutive days: last day to category
How should dermatologists manage contact allergies to botanicals?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, June 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Mark
New evaluation and management (E/M) coding changes are coming in 2021 – Practical applications of the 2021 E/M coding changes
Selecting the E/M level of service ... Part 3 of the "E/M coding changes are coming in 2021" series will focus on the practical application of the changes to dermatology-specific encounters based on ... medical decision making (MDM) or ... time . (Review ... part 1 and ... part 2
Best of DermWorld Insights and Inquiries
Dec. 26, 2024 We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2024 — starting with the most popular issue of the year. ... 1. Weighing in on glucagon-like
Coronavirus – Frequently Asked Media Questions
Talking points for members ... 1. How do you keep your hands from getting dry, given how often you have to wash them? What hand lotion do you use? After washing your hands, apply a petrolatum/mineral oil-based cream that is fragrance and dye free. Ointments and creams — the ones
Helpful tips on meeting with members of Congress and how to advocate and personally share the importance of the asks to you.
o This type of statement shifts from personal connections to policy and hits on general ideas like Medicare
Cannabis arteritis: Getting higher on the differential diagnosis list of ulcerative lesions
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, January 1, 2026 Vol. 8, No. 1 Marijuana use is on the rise. In 2022, nearly 22% of people had used the drug in the past year, with steep increases in the number of people 65 and older who
Et tu, Ibrutinib?
By Warren R. Heymann, MD July 8, 2020 Vol. 2, No. 27 When it comes to medications that I never prescribe, I learn from my patients who present with findings that compel me to do my homework. Such was the case of a middle-aged woman with chronic lymphocytic leukemia (CLL)
Nailing the diagnosis of the BAP1 tumor predisposition syndrome
By Warren R. Heymann, MD, FAAD June 5, 2024 Vol. 6, No. 23 I never imagined that I would be writing another commentary on onychopapillomas (Ops) so soon. The initial commentary was devoted to rare malignant Ops. (1) Unsurprisingly, additional reports of malignant Ops have been reported. (2) What else
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, July 2, 2018 I love a good disaster movie. Epic, poorly overacted tales of impossibly large hurricanes, tsunamis, tornados (even sharknados), and cataclysmic blizzards amuse me like no other movie genre. Like
2023 MIPS and telehealth highlights
Eligibility criteria ... The low volume threshold remains the same as 2022 and includes 3 aspects of covered professional services: ... Allowed charges ... Number of Medicare patients who receive services ... Number of services provided ... You must participate in MIPS (unless otherwise exempt) if, in both 12-month segments of
What does it mean when all of a patient's patch tests come back negative?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, September 2, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Erin Warshaw, MD, MS, about
AccessDerm: Serving the underserved
In Practice ... Dr. Simpson serves in the Department of Dermatology at University of Pennsylvania. ... By Dean Monti, managing editor, special publications, September 2, 2019 Dermatology World speaks with Cory Simpson, MD, PhD, about why he uses AccessDerm — the Academy's volunteer teledermatology platform — how it works, and
The evolution of practice settings
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, April 2, 2018 In my ... introductory column as your Academy President, I addressed the many changes facing dermatology and medicine. Over time we have found ourselves adapting to
2021 is finally here
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, January 1, 2021 While 2020 started off innocently enough, the cancellation of the Annual Meeting, shocking as it seemed at the time, was perhaps the first hint that this was not to
The times they are a-changin'
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, September 2, 2019 Who knew more than 50 years ago, that this iconic Bob Dylan song could apply to health care? The U.S. health care system has weathered
PDF of Drug interactions in dermatology, part 2
American Academy of Dermatology | Association boards fodder Drug Interactions in Dermatology, Part 2
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, Physician Editor, September 2, 2019 Last month, we introduced you to digital marketing. Many of our younger members already use their websites and social media platforms to successfully manage and highlight their
PDF of AAD Atopic Dermatitis pediatric comorbid conditions guideline draft
1 1 Article Type: From the Academy 2 3 Title: Guidelines of care for the primary prevention of
AAD Teledermatology Standards
Download a PDF version ... These ... AAD Teledermatology Standards are also available as a PDF. ... The standards below were developed by the Academy’s Teledermatology Committee at the direction of the Board of Directors. These standards expand upon the appropriate use of telemedicine and create a core set of
Tofacitinib: A JAK inhibitor of all trades
By Warren R. Heymann, MD April 3, 2019 Vol. 1, No. 4 The Janus kinase inhibitors are taking the dermatologic therapeutic world by storm — at least in the literature. By now, most dermatologists are familiar with studies that have demonstrated efficacy in alopecia areata, vitiligo, psoriasis, psoriatic arthritis, and
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, April 2, 2018 I hope you enjoyed the AAD Annual Meeting in San Diego. I certainly did. I came home yet again feeling renewed, returning to the clinic armed with new knowledge
PDF of PI #2, closing referral loops
of the patient's medication, including the name, dosage, frequency, and route of each medication; (2)
For patients with erythropoietic protoporphyria the tide has come in
By Warren Heymann, MD May 12, 2021 Vol. 3, No. 19 Oct. 8, 2019, was an eventful day for patients with erythopoietic protoporphyria (EPP) in the United States, when the FDA announced its approval of afamelanotide (Scenesse). (1) The drug was first approved in Italy in 2010. (2) ... Patients
Diabetes and your skin
Dermatologist explains how diabetes affects the skin and the importance of proper skin care ROSEMONT, Ill. (November 2, 2022) — Your skin is a window to your overall health, and what happens on your skin is often an indicator of what’s happening inside your body. Skin, hair, and nail conditions
PDF of AAD-28
Efficiency and Cost Reduction DESCRIPTION: Squamous cell carcinoma is the second most common type
PDF of Reporting Options Large Practices
COST (20%) IMPROVEMENT ACTIVITY (15%) QUALITY (40%) *Note must be engaged in activity for minimum 90
PDF of small and large practice guidance
QUALITY (40%) IMPROVEMENT ACTIVITY (15%) INSTRUCTIONS *Note must be engaged in activity for minimum 90
Something from nothing: The role of random skin biopsies
By Warren R. Heymann, MD Sept. 22, 2017 There are a few reports suggesting the usefulness of the random or blind skin biopsy from normal-appearing skin for diagnosis of intravascular lymphoma. Punch biopsy results from the abdomen. A, Intravascular large lymphoid cells. B, CD20+ tumor cells. (A, Hematoxylin-eosin stain; B,
An encapsulation of palisaded encapsulated neuromas
By Warren R. Heymann, MD, FAAD Jan. 22, 2025 Vol. 7, No. 3 You know the drill — a patient presents with a solitary, slowly enlarging, dome-shaped, non-pigmented painless facial papule and asks, "Is it skin cancer?" Your clinical and dermoscopic examinations are not definitive, so you respond with uncertainty,
MIPS Highlights for 2021
CMS announces automatic exemption for MIPS 2020 performance period & extended deadline for COVID relief ... In response to the ongoing COVID-19 public health emergency, CMS recently announced that it will apply an automatic extreme and uncontrollable circumstance (EUC) policy for all eligible clinicians for the MIPS program for the
2026 AAD Annual Meeting Fees, Session Access, and Eligibility PDF
Additional information can be found at aad.org/AM26 Physician members $1,080 $1,300 YES $95 $240 $470 $90
Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma
By Warren R. Heymann, MD, FAAD Aug. 20, 2025 Vol. 7, No. 33 As I write this commentary, March Madness is underway. According to the NCAA, the odds of predicting all 63 NCAA tournament games correctly are approximately 1 in 9.2 quintillion (a quintillion is 10 to the 18th power).
PDF of derm-specific COVID-19 resources
contact the Academy’s Practice Management Center: WEBSITE: aad.org/practicecenter Subject Page 2